WO2021256553A1 - リン酸基含有ポリマーを含むコーティング膜形成組成物 - Google Patents
リン酸基含有ポリマーを含むコーティング膜形成組成物 Download PDFInfo
- Publication number
- WO2021256553A1 WO2021256553A1 PCT/JP2021/023144 JP2021023144W WO2021256553A1 WO 2021256553 A1 WO2021256553 A1 WO 2021256553A1 JP 2021023144 W JP2021023144 W JP 2021023144W WO 2021256553 A1 WO2021256553 A1 WO 2021256553A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- coating film
- group
- formula
- forming composition
- polymer
- Prior art date
Links
- 238000000576 coating method Methods 0.000 title claims abstract description 114
- 239000011248 coating agent Substances 0.000 title claims abstract description 112
- 239000000203 mixture Substances 0.000 title claims abstract description 75
- 229920000642 polymer Polymers 0.000 title claims abstract description 49
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 title abstract description 10
- 230000015572 biosynthetic process Effects 0.000 title abstract description 9
- 239000002904 solvent Substances 0.000 claims abstract description 21
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims abstract description 14
- 239000000758 substrate Substances 0.000 claims abstract description 11
- 239000000126 substance Substances 0.000 claims description 25
- 125000004432 carbon atom Chemical group C* 0.000 claims description 22
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical group OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims description 19
- 125000000217 alkyl group Chemical group 0.000 claims description 15
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 15
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 7
- 229910052783 alkali metal Inorganic materials 0.000 claims description 5
- 125000002947 alkylene group Chemical group 0.000 claims description 5
- 229920001222 biopolymer Polymers 0.000 claims description 5
- 150000001340 alkali metals Chemical class 0.000 claims description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 3
- 229910052799 carbon Inorganic materials 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 239000012620 biological material Substances 0.000 claims description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 33
- 238000000034 method Methods 0.000 abstract description 11
- -1 polyoxyethylene Polymers 0.000 description 35
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 34
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 24
- 239000002953 phosphate buffered saline Substances 0.000 description 24
- 238000003380 quartz crystal microbalance Methods 0.000 description 20
- 150000001875 compounds Chemical class 0.000 description 18
- 210000004027 cell Anatomy 0.000 description 16
- 230000000052 comparative effect Effects 0.000 description 15
- 235000019441 ethanol Nutrition 0.000 description 15
- 102000053602 DNA Human genes 0.000 description 14
- 108020004414 DNA Proteins 0.000 description 14
- 229910052710 silicon Inorganic materials 0.000 description 14
- 239000010703 silicon Substances 0.000 description 14
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 13
- 238000001035 drying Methods 0.000 description 13
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 12
- 239000004793 Polystyrene Substances 0.000 description 12
- 238000005259 measurement Methods 0.000 description 12
- 150000002894 organic compounds Chemical class 0.000 description 12
- 229920002223 polystyrene Polymers 0.000 description 11
- 238000000961 QCM-D Methods 0.000 description 10
- 238000001179 sorption measurement Methods 0.000 description 10
- 229910052751 metal Inorganic materials 0.000 description 9
- 239000002184 metal Substances 0.000 description 9
- 239000000178 monomer Substances 0.000 description 9
- 239000000243 solution Substances 0.000 description 9
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 8
- 229920001577 copolymer Polymers 0.000 description 8
- IQPQWNKOIGAROB-UHFFFAOYSA-N isocyanate group Chemical group [N-]=C=O IQPQWNKOIGAROB-UHFFFAOYSA-N 0.000 description 8
- 102000004169 proteins and genes Human genes 0.000 description 8
- 108090000623 proteins and genes Proteins 0.000 description 8
- 239000004743 Polypropylene Substances 0.000 description 7
- 238000001641 gel filtration chromatography Methods 0.000 description 7
- 229920001155 polypropylene Polymers 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 239000002253 acid Substances 0.000 description 6
- 239000007864 aqueous solution Substances 0.000 description 6
- 125000000524 functional group Chemical group 0.000 description 6
- 230000010069 protein adhesion Effects 0.000 description 6
- 210000000130 stem cell Anatomy 0.000 description 6
- 238000003786 synthesis reaction Methods 0.000 description 6
- 239000002966 varnish Substances 0.000 description 6
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 5
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 5
- 102000039446 nucleic acids Human genes 0.000 description 5
- 108020004707 nucleic acids Proteins 0.000 description 5
- 150000007523 nucleic acids Chemical class 0.000 description 5
- 239000011347 resin Substances 0.000 description 5
- 229920005989 resin Polymers 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 4
- FRDAATYAJDYRNW-UHFFFAOYSA-N 3-methyl-3-pentanol Chemical compound CCC(C)(O)CC FRDAATYAJDYRNW-UHFFFAOYSA-N 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 4
- 238000004132 cross linking Methods 0.000 description 4
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 4
- ZSIAUFGUXNUGDI-UHFFFAOYSA-N hexan-1-ol Chemical compound CCCCCCO ZSIAUFGUXNUGDI-UHFFFAOYSA-N 0.000 description 4
- ZXEKIIBDNHEJCQ-UHFFFAOYSA-N isobutanol Chemical compound CC(C)CO ZXEKIIBDNHEJCQ-UHFFFAOYSA-N 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 239000004065 semiconductor Substances 0.000 description 4
- ZNQVEEAIQZEUHB-UHFFFAOYSA-N 2-ethoxyethanol Chemical compound CCOCCO ZNQVEEAIQZEUHB-UHFFFAOYSA-N 0.000 description 3
- QPRQEDXDYOZYLA-UHFFFAOYSA-N 2-methylbutan-1-ol Chemical compound CCC(C)CO QPRQEDXDYOZYLA-UHFFFAOYSA-N 0.000 description 3
- MSXVEPNJUHWQHW-UHFFFAOYSA-N 2-methylbutan-2-ol Chemical compound CCC(C)(C)O MSXVEPNJUHWQHW-UHFFFAOYSA-N 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 3
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical group CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- WOBHKFSMXKNTIM-UHFFFAOYSA-N Hydroxyethyl methacrylate Chemical compound CC(=C)C(=O)OCCO WOBHKFSMXKNTIM-UHFFFAOYSA-N 0.000 description 3
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- AMQJEAYHLZJPGS-UHFFFAOYSA-N N-Pentanol Chemical compound CCCCCO AMQJEAYHLZJPGS-UHFFFAOYSA-N 0.000 description 3
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 3
- 239000002202 Polyethylene glycol Substances 0.000 description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 150000001253 acrylic acids Chemical class 0.000 description 3
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 125000005340 bisphosphate group Chemical group 0.000 description 3
- 239000007975 buffered saline Substances 0.000 description 3
- BTANRVKWQNVYAZ-UHFFFAOYSA-N butan-2-ol Chemical compound CCC(C)O BTANRVKWQNVYAZ-UHFFFAOYSA-N 0.000 description 3
- 238000004140 cleaning Methods 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 239000003792 electrolyte Substances 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 238000004108 freeze drying Methods 0.000 description 3
- 108010074605 gamma-Globulins Proteins 0.000 description 3
- FFUAGWLWBBFQJT-UHFFFAOYSA-N hexamethyldisilazane Chemical compound C[Si](C)(C)N[Si](C)(C)C FFUAGWLWBBFQJT-UHFFFAOYSA-N 0.000 description 3
- 150000002500 ions Chemical class 0.000 description 3
- 229910044991 metal oxide Inorganic materials 0.000 description 3
- 239000011259 mixed solution Substances 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- KPSSIOMAKSHJJG-UHFFFAOYSA-N neopentyl alcohol Chemical compound CC(C)(C)CO KPSSIOMAKSHJJG-UHFFFAOYSA-N 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 239000003002 pH adjusting agent Substances 0.000 description 3
- 229910052698 phosphorus Inorganic materials 0.000 description 3
- 239000011574 phosphorus Substances 0.000 description 3
- 229920001223 polyethylene glycol Polymers 0.000 description 3
- 229920001451 polypropylene glycol Polymers 0.000 description 3
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 239000003507 refrigerant Substances 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 235000000346 sugar Nutrition 0.000 description 3
- 150000008163 sugars Chemical class 0.000 description 3
- 229920002818 (Hydroxyethyl)methacrylate Polymers 0.000 description 2
- BBMCTIGTTCKYKF-UHFFFAOYSA-N 1-heptanol Chemical compound CCCCCCCO BBMCTIGTTCKYKF-UHFFFAOYSA-N 0.000 description 2
- CETWDUZRCINIHU-UHFFFAOYSA-N 2-heptanol Chemical compound CCCCCC(C)O CETWDUZRCINIHU-UHFFFAOYSA-N 0.000 description 2
- PFNHSEQQEPMLNI-UHFFFAOYSA-N 2-methyl-1-pentanol Chemical compound CCCC(C)CO PFNHSEQQEPMLNI-UHFFFAOYSA-N 0.000 description 2
- WFRBDWRZVBPBDO-UHFFFAOYSA-N 2-methyl-2-pentanol Chemical compound CCCC(C)(C)O WFRBDWRZVBPBDO-UHFFFAOYSA-N 0.000 description 2
- ISTJMQSHILQAEC-UHFFFAOYSA-N 2-methyl-3-pentanol Chemical compound CCC(O)C(C)C ISTJMQSHILQAEC-UHFFFAOYSA-N 0.000 description 2
- NMZSJIQGMAGSSO-UHFFFAOYSA-N 3-[[1-amino-2-[[1-amino-1-(2-carboxyethylimino)-2-methylpropan-2-yl]diazenyl]-2-methylpropylidene]amino]propanoic acid Chemical compound OC(=O)CCNC(=N)C(C)(C)N=NC(C)(C)C(=N)NCCC(O)=O NMZSJIQGMAGSSO-UHFFFAOYSA-N 0.000 description 2
- IWTBVKIGCDZRPL-UHFFFAOYSA-N 3-methylpentanol Chemical compound CCC(C)CCO IWTBVKIGCDZRPL-UHFFFAOYSA-N 0.000 description 2
- FTOAOBMCPZCFFF-UHFFFAOYSA-N 5,5-diethylbarbituric acid Chemical compound CCC1(CC)C(=O)NC(=O)NC1=O FTOAOBMCPZCFFF-UHFFFAOYSA-N 0.000 description 2
- VVJKKWFAADXIJK-UHFFFAOYSA-N Allylamine Chemical group NCC=C VVJKKWFAADXIJK-UHFFFAOYSA-N 0.000 description 2
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- SOGAXMICEFXMKE-UHFFFAOYSA-N Butylmethacrylate Chemical compound CCCCOC(=O)C(C)=C SOGAXMICEFXMKE-UHFFFAOYSA-N 0.000 description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
- 229920002284 Cellulose triacetate Polymers 0.000 description 2
- 229920000089 Cyclic olefin copolymer Polymers 0.000 description 2
- OKKJLVBELUTLKV-MZCSYVLQSA-N Deuterated methanol Chemical compound [2H]OC([2H])([2H])[2H] OKKJLVBELUTLKV-MZCSYVLQSA-N 0.000 description 2
- 229920000219 Ethylene vinyl alcohol Polymers 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical group NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 2
- 239000000020 Nitrocellulose Substances 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- 239000004642 Polyimide Substances 0.000 description 2
- 239000004372 Polyvinyl alcohol Substances 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- 229920006362 Teflon® Polymers 0.000 description 2
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 2
- 239000004699 Ultra-high molecular weight polyethylene Substances 0.000 description 2
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N Valeric acid Natural products CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 description 2
- 235000010724 Wisteria floribunda Nutrition 0.000 description 2
- NNLVGZFZQQXQNW-ADJNRHBOSA-N [(2r,3r,4s,5r,6s)-4,5-diacetyloxy-3-[(2s,3r,4s,5r,6r)-3,4,5-triacetyloxy-6-(acetyloxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6s)-4,5,6-triacetyloxy-2-(acetyloxymethyl)oxan-3-yl]oxyoxan-2-yl]methyl acetate Chemical compound O([C@@H]1O[C@@H]([C@H]([C@H](OC(C)=O)[C@H]1OC(C)=O)O[C@H]1[C@@H]([C@@H](OC(C)=O)[C@H](OC(C)=O)[C@@H](COC(C)=O)O1)OC(C)=O)COC(=O)C)[C@@H]1[C@@H](COC(C)=O)O[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@H]1OC(C)=O NNLVGZFZQQXQNW-ADJNRHBOSA-N 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 235000011054 acetic acid Nutrition 0.000 description 2
- 229960000583 acetic acid Drugs 0.000 description 2
- XECAHXYUAAWDEL-UHFFFAOYSA-N acrylonitrile butadiene styrene Chemical compound C=CC=C.C=CC#N.C=CC1=CC=CC=C1 XECAHXYUAAWDEL-UHFFFAOYSA-N 0.000 description 2
- 239000004676 acrylonitrile butadiene styrene Substances 0.000 description 2
- 229920000122 acrylonitrile butadiene styrene Polymers 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- 125000003277 amino group Chemical group 0.000 description 2
- 150000001450 anions Chemical class 0.000 description 2
- 125000003710 aryl alkyl group Chemical group 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 229940098773 bovine serum albumin Drugs 0.000 description 2
- HQABUPZFAYXKJW-UHFFFAOYSA-N butan-1-amine Chemical group CCCCN HQABUPZFAYXKJW-UHFFFAOYSA-N 0.000 description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- YOQPKXIRWPWFIE-UHFFFAOYSA-N ctk4c8335 Chemical compound CC(=C)C(=O)OCCOP(=O)=O YOQPKXIRWPWFIE-UHFFFAOYSA-N 0.000 description 2
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 2
- PAFZNILMFXTMIY-UHFFFAOYSA-N cyclohexylamine Chemical group NC1CCCCC1 PAFZNILMFXTMIY-UHFFFAOYSA-N 0.000 description 2
- JQVDAXLFBXTEQA-UHFFFAOYSA-N dibutylamine Chemical group CCCCNCCCC JQVDAXLFBXTEQA-UHFFFAOYSA-N 0.000 description 2
- 239000004205 dimethyl polysiloxane Substances 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- DMBHHRLKUKUOEG-UHFFFAOYSA-N diphenylamine Chemical compound C=1C=CC=CC=1NC1=CC=CC=C1 DMBHHRLKUKUOEG-UHFFFAOYSA-N 0.000 description 2
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical group CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 2
- 125000003700 epoxy group Chemical group 0.000 description 2
- TUEYHEWXYWCDHA-UHFFFAOYSA-N ethyl 5-methylthiadiazole-4-carboxylate Chemical compound CCOC(=O)C=1N=NSC=1C TUEYHEWXYWCDHA-UHFFFAOYSA-N 0.000 description 2
- 125000000816 ethylene group Chemical group [H]C([H])([*:1])C([H])([H])[*:2] 0.000 description 2
- 239000004715 ethylene vinyl alcohol Substances 0.000 description 2
- 238000005227 gel permeation chromatography Methods 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- RZXDTJIXPSCHCI-UHFFFAOYSA-N hexa-1,5-diene-2,5-diol Chemical compound OC(=C)CCC(O)=C RZXDTJIXPSCHCI-UHFFFAOYSA-N 0.000 description 2
- QNVRIHYSUZMSGM-UHFFFAOYSA-N hexan-2-ol Chemical compound CCCCC(C)O QNVRIHYSUZMSGM-UHFFFAOYSA-N 0.000 description 2
- ZOCHHNOQQHDWHG-UHFFFAOYSA-N hexan-3-ol Chemical compound CCCC(O)CC ZOCHHNOQQHDWHG-UHFFFAOYSA-N 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- PHTQWCKDNZKARW-UHFFFAOYSA-N isoamylol Chemical compound CC(C)CCO PHTQWCKDNZKARW-UHFFFAOYSA-N 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 150000001247 metal acetylides Chemical class 0.000 description 2
- 150000004706 metal oxides Chemical group 0.000 description 2
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 description 2
- 150000007522 mineralic acids Chemical class 0.000 description 2
- 239000000025 natural resin Substances 0.000 description 2
- 150000004767 nitrides Chemical class 0.000 description 2
- 229920001220 nitrocellulos Polymers 0.000 description 2
- FBUKVWPVBMHYJY-UHFFFAOYSA-N nonanoic acid Chemical compound CCCCCCCCC(O)=O FBUKVWPVBMHYJY-UHFFFAOYSA-N 0.000 description 2
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- DPBLXKKOBLCELK-UHFFFAOYSA-N pentan-1-amine Chemical group CCCCCN DPBLXKKOBLCELK-UHFFFAOYSA-N 0.000 description 2
- JYVLIDXNZAXMDK-UHFFFAOYSA-N pentan-2-ol Chemical compound CCCC(C)O JYVLIDXNZAXMDK-UHFFFAOYSA-N 0.000 description 2
- AQIXEPGDORPWBJ-UHFFFAOYSA-N pentan-3-ol Chemical compound CCC(O)CC AQIXEPGDORPWBJ-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 2
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 2
- 229920002492 poly(sulfone) Polymers 0.000 description 2
- 229920002239 polyacrylonitrile Polymers 0.000 description 2
- 229920000728 polyester Polymers 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 229920000139 polyethylene terephthalate Polymers 0.000 description 2
- 239000005020 polyethylene terephthalate Substances 0.000 description 2
- 229920001721 polyimide Polymers 0.000 description 2
- 238000006116 polymerization reaction Methods 0.000 description 2
- 230000000379 polymerizing effect Effects 0.000 description 2
- 239000004926 polymethyl methacrylate Substances 0.000 description 2
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 2
- 239000004810 polytetrafluoroethylene Substances 0.000 description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- WGYKZJWCGVVSQN-UHFFFAOYSA-N propylamine Chemical group CCCN WGYKZJWCGVVSQN-UHFFFAOYSA-N 0.000 description 2
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 229920002477 rna polymer Polymers 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 238000000859 sublimation Methods 0.000 description 2
- 230000008022 sublimation Effects 0.000 description 2
- 125000000383 tetramethylene group Chemical group [H]C([H])([*:1])C([H])([H])C([H])([H])C([H])([H])[*:2] 0.000 description 2
- 230000036962 time dependent Effects 0.000 description 2
- 125000003258 trimethylene group Chemical group [H]C([H])([*:2])C([H])([H])C([H])([H])[*:1] 0.000 description 2
- 229920000785 ultra high molecular weight polyethylene Polymers 0.000 description 2
- 108010047303 von Willebrand Factor Proteins 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical group C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- WYTZZXDRDKSJID-UHFFFAOYSA-N (3-aminopropyl)triethoxysilane Chemical compound CCO[Si](OCC)(OCC)CCCN WYTZZXDRDKSJID-UHFFFAOYSA-N 0.000 description 1
- 239000001618 (3R)-3-methylpentan-1-ol Substances 0.000 description 1
- FKTHNVSLHLHISI-UHFFFAOYSA-N 1,2-bis(isocyanatomethyl)benzene Chemical compound O=C=NCC1=CC=CC=C1CN=C=O FKTHNVSLHLHISI-UHFFFAOYSA-N 0.000 description 1
- ZTNJGMFHJYGMDR-UHFFFAOYSA-N 1,2-diisocyanatoethane Chemical compound O=C=NCCN=C=O ZTNJGMFHJYGMDR-UHFFFAOYSA-N 0.000 description 1
- XSCLFFBWRKTMTE-UHFFFAOYSA-N 1,3-bis(isocyanatomethyl)cyclohexane Chemical compound O=C=NCC1CCCC(CN=C=O)C1 XSCLFFBWRKTMTE-UHFFFAOYSA-N 0.000 description 1
- OVBFMUAFNIIQAL-UHFFFAOYSA-N 1,4-diisocyanatobutane Chemical compound O=C=NCCCCN=C=O OVBFMUAFNIIQAL-UHFFFAOYSA-N 0.000 description 1
- ATOUXIOKEJWULN-UHFFFAOYSA-N 1,6-diisocyanato-2,2,4-trimethylhexane Chemical compound O=C=NCCC(C)CC(C)(C)CN=C=O ATOUXIOKEJWULN-UHFFFAOYSA-N 0.000 description 1
- KBPLFHHGFOOTCA-UHFFFAOYSA-N 1-Octanol Chemical group CCCCCCCCO KBPLFHHGFOOTCA-UHFFFAOYSA-N 0.000 description 1
- GYSCBCSGKXNZRH-UHFFFAOYSA-N 1-benzothiophene-2-carboxamide Chemical compound C1=CC=C2SC(C(=O)N)=CC2=C1 GYSCBCSGKXNZRH-UHFFFAOYSA-N 0.000 description 1
- BMVXCPBXGZKUPN-UHFFFAOYSA-N 1-hexanamine Chemical group CCCCCCN BMVXCPBXGZKUPN-UHFFFAOYSA-N 0.000 description 1
- YIDSTEJLDQMWBR-UHFFFAOYSA-N 1-isocyanatododecane Chemical compound CCCCCCCCCCCCN=C=O YIDSTEJLDQMWBR-UHFFFAOYSA-N 0.000 description 1
- DYQFCTCUULUMTQ-UHFFFAOYSA-N 1-isocyanatooctane Chemical compound CCCCCCCCN=C=O DYQFCTCUULUMTQ-UHFFFAOYSA-N 0.000 description 1
- VRVUKQWNRPNACD-UHFFFAOYSA-N 1-isocyanatopentane Chemical compound CCCCCN=C=O VRVUKQWNRPNACD-UHFFFAOYSA-N 0.000 description 1
- 125000004809 1-methylpropylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])C([H])([H])[*:2] 0.000 description 1
- FRPZMMHWLSIFAZ-UHFFFAOYSA-N 10-undecenoic acid Chemical compound OC(=O)CCCCCCCCC=C FRPZMMHWLSIFAZ-UHFFFAOYSA-N 0.000 description 1
- KIPSRYDSZQRPEA-UHFFFAOYSA-N 2,2,2-trifluoroethanamine Chemical compound NCC(F)(F)F KIPSRYDSZQRPEA-UHFFFAOYSA-N 0.000 description 1
- IKECULIHBUCAKR-UHFFFAOYSA-N 2,3-dimethylbutan-2-ol Chemical compound CC(C)C(C)(C)O IKECULIHBUCAKR-UHFFFAOYSA-N 0.000 description 1
- STMDPCBYJCIZOD-UHFFFAOYSA-N 2-(2,4-dinitroanilino)-4-methylpentanoic acid Chemical compound CC(C)CC(C(O)=O)NC1=CC=C([N+]([O-])=O)C=C1[N+]([O-])=O STMDPCBYJCIZOD-UHFFFAOYSA-N 0.000 description 1
- BBBUAWSVILPJLL-UHFFFAOYSA-N 2-(2-ethylhexoxymethyl)oxirane Chemical compound CCCCC(CC)COCC1CO1 BBBUAWSVILPJLL-UHFFFAOYSA-N 0.000 description 1
- SBASXUCJHJRPEV-UHFFFAOYSA-N 2-(2-methoxyethoxy)ethanol Chemical group COCCOCCO SBASXUCJHJRPEV-UHFFFAOYSA-N 0.000 description 1
- DRSDQADBHIDJCU-UHFFFAOYSA-N 2-(3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluorooctoxymethyl)oxirane Chemical compound FC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)CCOCC1CO1 DRSDQADBHIDJCU-UHFFFAOYSA-N 0.000 description 1
- VMSIYTPWZLSMOH-UHFFFAOYSA-N 2-(dodecoxymethyl)oxirane Chemical compound CCCCCCCCCCCCOCC1CO1 VMSIYTPWZLSMOH-UHFFFAOYSA-N 0.000 description 1
- QNVRIHYSUZMSGM-LURJTMIESA-N 2-Hexanol Natural products CCCC[C@H](C)O QNVRIHYSUZMSGM-LURJTMIESA-N 0.000 description 1
- WFSMVVDJSNMRAR-UHFFFAOYSA-N 2-[2-(2-ethoxyethoxy)ethoxy]ethanol Chemical compound CCOCCOCCOCCO WFSMVVDJSNMRAR-UHFFFAOYSA-N 0.000 description 1
- MUUOUUYKIVSIAR-UHFFFAOYSA-N 2-but-3-enyloxirane Chemical compound C=CCCC1CO1 MUUOUUYKIVSIAR-UHFFFAOYSA-N 0.000 description 1
- WHNBDXQTMPYBAT-UHFFFAOYSA-N 2-butyloxirane Chemical compound CCCCC1CO1 WHNBDXQTMPYBAT-UHFFFAOYSA-N 0.000 description 1
- TZYRSLHNPKPEFV-UHFFFAOYSA-N 2-ethyl-1-butanol Chemical compound CCC(CC)CO TZYRSLHNPKPEFV-UHFFFAOYSA-N 0.000 description 1
- DPNXHTDWGGVXID-UHFFFAOYSA-N 2-isocyanatoethyl prop-2-enoate Chemical compound C=CC(=O)OCCN=C=O DPNXHTDWGGVXID-UHFFFAOYSA-N 0.000 description 1
- 125000004493 2-methylbut-1-yl group Chemical group CC(C*)CC 0.000 description 1
- 125000004810 2-methylpropylene group Chemical group [H]C([H])([H])C([H])(C([H])([H])[*:2])C([H])([H])[*:1] 0.000 description 1
- AAMHBRRZYSORSH-UHFFFAOYSA-N 2-octyloxirane Chemical compound CCCCCCCCC1CO1 AAMHBRRZYSORSH-UHFFFAOYSA-N 0.000 description 1
- NMOFYYYCFRVWBK-UHFFFAOYSA-N 2-pentyloxirane Chemical compound CCCCCC1CO1 NMOFYYYCFRVWBK-UHFFFAOYSA-N 0.000 description 1
- WLJVXDMOQOGPHL-PPJXEINESA-N 2-phenylacetic acid Chemical compound O[14C](=O)CC1=CC=CC=C1 WLJVXDMOQOGPHL-PPJXEINESA-N 0.000 description 1
- 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 1
- DUXCSEISVMREAX-UHFFFAOYSA-N 3,3-dimethylbutan-1-ol Chemical compound CC(C)(C)CCO DUXCSEISVMREAX-UHFFFAOYSA-N 0.000 description 1
- ZXNBBWHRUSXUFZ-UHFFFAOYSA-N 3-methyl-2-pentanol Chemical compound CCC(C)C(C)O ZXNBBWHRUSXUFZ-UHFFFAOYSA-N 0.000 description 1
- 125000003542 3-methylbutan-2-yl group Chemical group [H]C([H])([H])C([H])(*)C([H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- SJECZPVISLOESU-UHFFFAOYSA-N 3-trimethoxysilylpropan-1-amine Chemical compound CO[Si](OC)(OC)CCCN SJECZPVISLOESU-UHFFFAOYSA-N 0.000 description 1
- WVYWICLMDOOCFB-UHFFFAOYSA-N 4-methyl-2-pentanol Chemical compound CC(C)CC(C)O WVYWICLMDOOCFB-UHFFFAOYSA-N 0.000 description 1
- PCWGTDULNUVNBN-UHFFFAOYSA-N 4-methylpentan-1-ol Chemical compound CC(C)CCCO PCWGTDULNUVNBN-UHFFFAOYSA-N 0.000 description 1
- AWQSAIIDOMEEOD-UHFFFAOYSA-N 5,5-Dimethyl-4-(3-oxobutyl)dihydro-2(3H)-furanone Chemical compound CC(=O)CCC1CC(=O)OC1(C)C AWQSAIIDOMEEOD-UHFFFAOYSA-N 0.000 description 1
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 210000002237 B-cell of pancreatic islet Anatomy 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- USACDPVEDUXRQQ-UHFFFAOYSA-N CCCOP(=O)(OOC(=O)C(=C)C)OOC(=O)C(=C)C Chemical compound CCCOP(=O)(OOC(=O)C(=C)C)OOC(=O)C(=C)C USACDPVEDUXRQQ-UHFFFAOYSA-N 0.000 description 1
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 1
- 206010008342 Cervix carcinoma Diseases 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 102100030497 Cytochrome c Human genes 0.000 description 1
- 108010075031 Cytochromes c Proteins 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- GHVNFZFCNZKVNT-UHFFFAOYSA-N Decanoic acid Natural products CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 108010049003 Fibrinogen Proteins 0.000 description 1
- 102000008946 Fibrinogen Human genes 0.000 description 1
- 102000016359 Fibronectins Human genes 0.000 description 1
- 108010067306 Fibronectins Proteins 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 108010044091 Globulins Proteins 0.000 description 1
- 102000006395 Globulins Human genes 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 239000005057 Hexamethylene diisocyanate Substances 0.000 description 1
- 108010033040 Histones Proteins 0.000 description 1
- 101000600434 Homo sapiens Putative uncharacterized protein encoded by MIR7-3HG Proteins 0.000 description 1
- 108091006905 Human Serum Albumin Proteins 0.000 description 1
- 102000008100 Human Serum Albumin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 239000005058 Isophorone diisocyanate Substances 0.000 description 1
- 108010007622 LDL Lipoproteins Proteins 0.000 description 1
- 102000007330 LDL Lipoproteins Human genes 0.000 description 1
- 102000004856 Lectins Human genes 0.000 description 1
- 108090001090 Lectins Proteins 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Natural products O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 1
- MBBZMMPHUWSWHV-BDVNFPICSA-N N-methylglucamine Chemical compound CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO MBBZMMPHUWSWHV-BDVNFPICSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 1
- 239000002033 PVDF binder Substances 0.000 description 1
- 102000057297 Pepsin A Human genes 0.000 description 1
- 108090000284 Pepsin A Proteins 0.000 description 1
- 229920012266 Poly(ether sulfone) PES Polymers 0.000 description 1
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical compound CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 1
- 102100037401 Putative uncharacterized protein encoded by MIR7-3HG Human genes 0.000 description 1
- 108010083644 Ribonucleases Proteins 0.000 description 1
- 102000006382 Ribonucleases Human genes 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 239000004809 Teflon Substances 0.000 description 1
- 239000007984 Tris EDTA buffer Substances 0.000 description 1
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- AWBASQCACWFTGD-UHFFFAOYSA-N [5-amino-2-[[[5-amino-2-(hydroxymethyl)oxolan-3-yl]oxy-hydroxyphosphoryl]oxymethyl]oxolan-3-yl] (5-amino-3-hydroxyoxolan-2-yl)methyl hydrogen phosphate Chemical compound O1C(N)CC(O)C1COP(O)(=O)OC1C(COP(O)(=O)OC2C(OC(N)C2)CO)OC(N)C1 AWBASQCACWFTGD-UHFFFAOYSA-N 0.000 description 1
- MZVQCMJNVPIDEA-UHFFFAOYSA-N [CH2]CN(CC)CC Chemical group [CH2]CN(CC)CC MZVQCMJNVPIDEA-UHFFFAOYSA-N 0.000 description 1
- HZEWFHLRYVTOIW-UHFFFAOYSA-N [Ti].[Ni] Chemical compound [Ti].[Ni] HZEWFHLRYVTOIW-UHFFFAOYSA-N 0.000 description 1
- XVIYCJDWYLJQBG-UHFFFAOYSA-N acetic acid;adamantane Chemical compound CC(O)=O.C1C(C2)CC3CC1CC2C3 XVIYCJDWYLJQBG-UHFFFAOYSA-N 0.000 description 1
- 210000001789 adipocyte Anatomy 0.000 description 1
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 1
- 125000005907 alkyl ester group Chemical group 0.000 description 1
- 229910045601 alloy Inorganic materials 0.000 description 1
- 239000000956 alloy Substances 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- OBETXYAYXDNJHR-UHFFFAOYSA-N alpha-ethylcaproic acid Natural products CCCCC(CC)C(O)=O OBETXYAYXDNJHR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- DKNWSYNQZKUICI-UHFFFAOYSA-N amantadine Chemical group C1C(C2)CC3CC2CC1(N)C3 DKNWSYNQZKUICI-UHFFFAOYSA-N 0.000 description 1
- 229960003805 amantadine Drugs 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 125000005160 aryl oxy alkyl group Chemical group 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 210000003719 b-lymphocyte Anatomy 0.000 description 1
- 229960002319 barbital Drugs 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 229960004365 benzoic acid Drugs 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 229920001400 block copolymer Polymers 0.000 description 1
- 210000001772 blood platelet Anatomy 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 210000002449 bone cell Anatomy 0.000 description 1
- 210000002798 bone marrow cell Anatomy 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229910052792 caesium Inorganic materials 0.000 description 1
- TVFDJXOCXUVLDH-UHFFFAOYSA-N caesium atom Chemical compound [Cs] TVFDJXOCXUVLDH-UHFFFAOYSA-N 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- VPKDCDLSJZCGKE-UHFFFAOYSA-N carbodiimide group Chemical group N=C=N VPKDCDLSJZCGKE-UHFFFAOYSA-N 0.000 description 1
- 235000011089 carbon dioxide Nutrition 0.000 description 1
- 210000003321 cartilage cell Anatomy 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 230000021164 cell adhesion Effects 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 201000010881 cervical cancer Diseases 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 210000004978 chinese hamster ovary cell Anatomy 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 239000008199 coating composition Substances 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000011365 complex material Substances 0.000 description 1
- 238000006482 condensation reaction Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 125000000753 cycloalkyl group Chemical group 0.000 description 1
- HPXRVTGHNJAIIH-UHFFFAOYSA-N cyclohexanol Chemical compound OC1CCCCC1 HPXRVTGHNJAIIH-UHFFFAOYSA-N 0.000 description 1
- KQWGXHWJMSMDJJ-UHFFFAOYSA-N cyclohexyl isocyanate Chemical compound O=C=NC1CCCCC1 KQWGXHWJMSMDJJ-UHFFFAOYSA-N 0.000 description 1
- XCIXKGXIYUWCLL-UHFFFAOYSA-N cyclopentanol Chemical compound OC1CCCC1 XCIXKGXIYUWCLL-UHFFFAOYSA-N 0.000 description 1
- 238000005262 decarbonization Methods 0.000 description 1
- 210000004443 dendritic cell Anatomy 0.000 description 1
- 229960000633 dextran sulfate Drugs 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- OTARVPUIYXHRRB-UHFFFAOYSA-N diethoxy-methyl-[3-(oxiran-2-ylmethoxy)propyl]silane Chemical compound CCO[Si](C)(OCC)CCCOCC1CO1 OTARVPUIYXHRRB-UHFFFAOYSA-N 0.000 description 1
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical group CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 1
- XXJWXESWEXIICW-UHFFFAOYSA-N diethylene glycol monoethyl ether Chemical group CCOCCOCCO XXJWXESWEXIICW-UHFFFAOYSA-N 0.000 description 1
- 229940075557 diethylene glycol monoethyl ether Drugs 0.000 description 1
- 125000005442 diisocyanate group Chemical group 0.000 description 1
- 238000003618 dip coating Methods 0.000 description 1
- WEHWNAOGRSTTBQ-UHFFFAOYSA-N dipropylamine Chemical group CCCNCCC WEHWNAOGRSTTBQ-UHFFFAOYSA-N 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- JRBPAEWTRLWTQC-UHFFFAOYSA-N dodecylamine Chemical group CCCCCCCCCCCCN JRBPAEWTRLWTQC-UHFFFAOYSA-N 0.000 description 1
- 235000014103 egg white Nutrition 0.000 description 1
- 210000000969 egg white Anatomy 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 210000001671 embryonic stem cell Anatomy 0.000 description 1
- 238000007720 emulsion polymerization reaction Methods 0.000 description 1
- 210000001339 epidermal cell Anatomy 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- FPIQZBQZKBKLEI-UHFFFAOYSA-N ethyl 1-[[2-chloroethyl(nitroso)carbamoyl]amino]cyclohexane-1-carboxylate Chemical compound ClCCN(N=O)C(=O)NC1(C(=O)OCC)CCCCC1 FPIQZBQZKBKLEI-UHFFFAOYSA-N 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 229940012952 fibrinogen Drugs 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 229910052730 francium Inorganic materials 0.000 description 1
- KLMCZVJOEAUDNE-UHFFFAOYSA-N francium atom Chemical compound [Fr] KLMCZVJOEAUDNE-UHFFFAOYSA-N 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 229920000578 graft copolymer Polymers 0.000 description 1
- 230000003394 haemopoietic effect Effects 0.000 description 1
- 210000003780 hair follicle Anatomy 0.000 description 1
- 210000002064 heart cell Anatomy 0.000 description 1
- 210000003958 hematopoietic stem cell Anatomy 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 210000003897 hepatic stem cell Anatomy 0.000 description 1
- RRAMGCGOFNQTLD-UHFFFAOYSA-N hexamethylene diisocyanate Chemical compound O=C=NCCCCCCN=C=O RRAMGCGOFNQTLD-UHFFFAOYSA-N 0.000 description 1
- ANJPRQPHZGHVQB-UHFFFAOYSA-N hexyl isocyanate Chemical compound CCCCCCN=C=O ANJPRQPHZGHVQB-UHFFFAOYSA-N 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 150000002484 inorganic compounds Chemical class 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 229910003480 inorganic solid Inorganic materials 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 210000004966 intestinal stem cell Anatomy 0.000 description 1
- 238000012690 ionic polymerization Methods 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- YDNLNVZZTACNJX-UHFFFAOYSA-N isocyanatomethylbenzene Chemical compound O=C=NCC1=CC=CC=C1 YDNLNVZZTACNJX-UHFFFAOYSA-N 0.000 description 1
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 1
- NIMLQBUJDJZYEJ-UHFFFAOYSA-N isophorone diisocyanate Chemical compound CC1(C)CC(N=C=O)CC(C)(CN=C=O)C1 NIMLQBUJDJZYEJ-UHFFFAOYSA-N 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 210000002510 keratinocyte Anatomy 0.000 description 1
- 210000003292 kidney cell Anatomy 0.000 description 1
- 239000002523 lectin Substances 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 210000002901 mesenchymal stem cell Anatomy 0.000 description 1
- 229910001507 metal halide Inorganic materials 0.000 description 1
- 150000005309 metal halides Chemical class 0.000 description 1
- 229910052752 metalloid Inorganic materials 0.000 description 1
- 150000002738 metalloids Chemical class 0.000 description 1
- GEJHIUFJTCYNSC-UHFFFAOYSA-N methyl 1-[(1-methoxycarbonylcyclohexyl)diazenyl]cyclohexane-1-carboxylate Chemical compound C1CCCCC1(C(=O)OC)N=NC1(C(=O)OC)CCCCC1 GEJHIUFJTCYNSC-UHFFFAOYSA-N 0.000 description 1
- 210000000274 microglia Anatomy 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 210000005087 mononuclear cell Anatomy 0.000 description 1
- 210000000663 muscle cell Anatomy 0.000 description 1
- 210000001665 muscle stem cell Anatomy 0.000 description 1
- KBJFYLLAMSZSOG-UHFFFAOYSA-N n-(3-trimethoxysilylpropyl)aniline Chemical compound CO[Si](OC)(OC)CCCNC1=CC=CC=C1 KBJFYLLAMSZSOG-UHFFFAOYSA-N 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- HNHVTXYLRVGMHD-UHFFFAOYSA-N n-butyl isocyanate Chemical compound CCCCN=C=O HNHVTXYLRVGMHD-UHFFFAOYSA-N 0.000 description 1
- QQZOPKMRPOGIEB-UHFFFAOYSA-N n-butyl methyl ketone Natural products CCCCC(C)=O QQZOPKMRPOGIEB-UHFFFAOYSA-N 0.000 description 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001971 neopentyl group Chemical group [H]C([*])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 210000004498 neuroglial cell Anatomy 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 210000000440 neutrophil Anatomy 0.000 description 1
- 229910001000 nickel titanium Inorganic materials 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- IOQPZZOEVPZRBK-UHFFFAOYSA-N octan-1-amine Chemical group CCCCCCCCN IOQPZZOEVPZRBK-UHFFFAOYSA-N 0.000 description 1
- 210000004248 oligodendroglia Anatomy 0.000 description 1
- 210000004738 parenchymal cell Anatomy 0.000 description 1
- 125000003538 pentan-3-yl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])[H] 0.000 description 1
- 229940100684 pentylamine Drugs 0.000 description 1
- 229940111202 pepsin Drugs 0.000 description 1
- 102000013415 peroxidase activity proteins Human genes 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- DFOXKPDFWGNLJU-UHFFFAOYSA-N pinacolyl alcohol Chemical compound CC(O)C(C)(C)C DFOXKPDFWGNLJU-UHFFFAOYSA-N 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 210000001778 pluripotent stem cell Anatomy 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 229920002981 polyvinylidene fluoride Polymers 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M potassium chloride Inorganic materials [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 229940095574 propionic acid Drugs 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 238000010526 radical polymerization reaction Methods 0.000 description 1
- 229920005604 random copolymer Polymers 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 229910052701 rubidium Inorganic materials 0.000 description 1
- IGLNJRXAVVLDKE-UHFFFAOYSA-N rubidium atom Chemical compound [Rb] IGLNJRXAVVLDKE-UHFFFAOYSA-N 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 125000003548 sec-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000004447 silicone coating Substances 0.000 description 1
- 210000002363 skeletal muscle cell Anatomy 0.000 description 1
- 210000000329 smooth muscle myocyte Anatomy 0.000 description 1
- 239000011343 solid material Substances 0.000 description 1
- 238000007711 solidification Methods 0.000 description 1
- 230000008023 solidification Effects 0.000 description 1
- 238000000807 solvent casting Methods 0.000 description 1
- 238000004528 spin coating Methods 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 229920003002 synthetic resin Polymers 0.000 description 1
- 239000000057 synthetic resin Substances 0.000 description 1
- ADXGNEYLLLSOAR-UHFFFAOYSA-N tasosartan Chemical compound C12=NC(C)=NC(C)=C2CCC(=O)N1CC(C=C1)=CC=C1C1=CC=CC=C1C=1N=NNN=1 ADXGNEYLLLSOAR-UHFFFAOYSA-N 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000001973 tert-pentyl group Chemical group [H]C([H])([H])C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 150000003573 thiols Chemical class 0.000 description 1
- IAQRGUVFOMOMEM-ONEGZZNKSA-N trans-but-2-ene Chemical group C\C=C\C IAQRGUVFOMOMEM-ONEGZZNKSA-N 0.000 description 1
- ZIBGPFATKBEMQZ-UHFFFAOYSA-N triethylene glycol Chemical compound OCCOCCOCCO ZIBGPFATKBEMQZ-UHFFFAOYSA-N 0.000 description 1
- JLGLQAWTXXGVEM-UHFFFAOYSA-N triethylene glycol monomethyl ether Chemical compound COCCOCCOCCO JLGLQAWTXXGVEM-UHFFFAOYSA-N 0.000 description 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 1
- WVLBCYQITXONBZ-UHFFFAOYSA-N trimethyl phosphate Chemical compound COP(=O)(OC)OC WVLBCYQITXONBZ-UHFFFAOYSA-N 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 239000003656 tris buffered saline Substances 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 229910021642 ultra pure water Inorganic materials 0.000 description 1
- 239000012498 ultrapure water Substances 0.000 description 1
- 238000009777 vacuum freeze-drying Methods 0.000 description 1
- 210000003556 vascular endothelial cell Anatomy 0.000 description 1
- ZTWTYVWXUKTLCP-UHFFFAOYSA-N vinylphosphonic acid Chemical compound OP(O)(=O)C=C ZTWTYVWXUKTLCP-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J7/00—Chemical treatment or coating of shaped articles made of macromolecular substances
- C08J7/04—Coating
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09D—COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
- C09D143/00—Coating compositions based on homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and containing boron, silicon, phosphorus, selenium, tellurium, or a metal; Coating compositions based on derivatives of such polymers
- C09D143/02—Homopolymers or copolymers of monomers containing phosphorus
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F230/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and containing phosphorus, selenium, tellurium or a metal
- C08F230/02—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and containing phosphorus, selenium, tellurium or a metal containing phosphorus
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L79/00—Compositions of macromolecular compounds obtained by reactions forming in the main chain of the macromolecule a linkage containing nitrogen with or without oxygen or carbon only, not provided for in groups C08L61/00 - C08L77/00
- C08L79/04—Polycondensates having nitrogen-containing heterocyclic rings in the main chain; Polyhydrazides; Polyamide acids or similar polyimide precursors
- C08L79/08—Polyimides; Polyester-imides; Polyamide-imides; Polyamide acids or similar polyimide precursors
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09D—COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
- C09D133/00—Coating compositions based on homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides, or nitriles thereof; Coating compositions based on derivatives of such polymers
- C09D133/04—Homopolymers or copolymers of esters
- C09D133/06—Homopolymers or copolymers of esters of esters containing only carbon, hydrogen and oxygen, the oxygen atom being present only as part of the carboxyl radical
- C09D133/10—Homopolymers or copolymers of methacrylic acid esters
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09D—COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
- C09D179/00—Coating compositions based on macromolecular compounds obtained by reactions forming in the main chain of the macromolecule a linkage containing nitrogen, with or without oxygen, or carbon only, not provided for in groups C09D161/00 - C09D177/00
- C09D179/04—Polycondensates having nitrogen-containing heterocyclic rings in the main chain; Polyhydrazides; Polyamide acids or similar polyimide precursors
- C09D179/08—Polyimides; Polyester-imides; Polyamide-imides; Polyamide acids or similar polyimide precursors
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09D—COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
- C09D201/00—Coating compositions based on unspecified macromolecular compounds
- C09D201/02—Coating compositions based on unspecified macromolecular compounds characterised by the presence of specified groups, e.g. terminal or pendant functional groups
- C09D201/06—Coating compositions based on unspecified macromolecular compounds characterised by the presence of specified groups, e.g. terminal or pendant functional groups containing oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09D—COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
- C09D5/00—Coating compositions, e.g. paints, varnishes or lacquers, characterised by their physical nature or the effects produced; Filling pastes
- C09D5/16—Antifouling paints; Underwater paints
- C09D5/1656—Antifouling paints; Underwater paints characterised by the film-forming substance
- C09D5/1662—Synthetic film-forming substance
- C09D5/1668—Vinyl-type polymers
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09D—COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
- C09D7/00—Features of coating compositions, not provided for in group C09D5/00; Processes for incorporating ingredients in coating compositions
- C09D7/20—Diluents or solvents
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2333/00—Characterised by the use of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides, or nitriles thereof; Derivatives of such polymers
- C08J2333/04—Characterised by the use of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides, or nitriles thereof; Derivatives of such polymers esters
- C08J2333/06—Characterised by the use of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides, or nitriles thereof; Derivatives of such polymers esters of esters containing only carbon, hydrogen, and oxygen, the oxygen atom being present only as part of the carboxyl radical
- C08J2333/10—Homopolymers or copolymers of methacrylic acid esters
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2379/00—Characterised by the use of macromolecular compounds obtained by reactions forming in the main chain of the macromolecule a linkage containing nitrogen with or without oxygen, or carbon only, not provided for in groups C08J2361/00 - C08J2377/00
- C08J2379/04—Polycondensates having nitrogen-containing heterocyclic rings in the main chain; Polyhydrazides; Polyamide acids or similar polyimide precursors
- C08J2379/08—Polyimides; Polyester-imides; Polyamide-imides; Polyamide acids or similar polyimide precursors
Definitions
- the present invention relates to a coating film forming composition containing a phosphoric acid group-containing polymer, and a coating film which is a cured product of the composition.
- Patent Document 1 discloses an ion complex material containing a phosphate group-containing polymer.
- Patent Document 2 discloses an aqueous metallic coating composition using a phosphoric acid polymer.
- the present invention can form a film on a substrate or the like by a simple process, and can maintain the film performance such as the ability to suppress the adhesion of biological substances and the hydrophilicity of the surface in a solvent environment containing water, and contains a phosphate group. It is an object of the present invention to provide a coating film forming composition containing a polymer, and a coating film which is a cured product of the composition.
- the present invention includes the following.
- the polymer (P) is the formula (a) or the formula (a-1): [In the formula (a), U a1 and U a2 each independently represent a hydrogen atom or an alkyl group having 1 to 5 carbon atoms, and at least one of U a1 and U a 2 is a hydrogen atom, and the formula is The coating film-forming composition according to [1], wherein A in (a-1) contains a group represented by [representing an alkali metal].
- the polymer (P) has the formula (1): [In the formula, R 11 represents a hydrogen atom or an alkyl group having 1 to 5 carbon atoms, X 1 represents an alkylene group having 1 to 5 carbon atoms, and n1 represents an integer of 1 to 10.
- the hydrophilic group has the following formula (I): (In the formula, R 1 represents an alkyl group having a carbon number of 1 ⁇ 5, R 2 represents a hydrogen atom or a methyl group, if R 2 there are a plurality, said R 2 is either the same or different from each other
- a coating film which is a cured product of the coating film of the coating film forming composition according to any one of [1] to [7].
- a method for producing a coating film which comprises a step of applying the coating film forming composition according to any one of [1] to [7] to a substrate.
- the coating film-forming composition containing the phosphoric acid group-containing polymer of the present invention has storage stability even if it contains water as a solvent, and the coating film made of the composition can be used as a solvent containing water or the like. Has excellent durability.
- the coating film made of the composition of the present invention has the ability to suppress the adhesion of biopolymers as a cured film without elution even in water. In particular, it has an excellent ability to suppress adhesion to biopolymers.
- the results of the protein adhesion test (QCM-D measurement) on the QCM sensor surface-treated with the coating film forming compositions of Examples 1 and Comparative Examples 1 and 2 evaluated in Test Example 1 are obtained by measuring the mass per unit area. It is shown in a time-dependent graph.
- the results of the DNA adhesion test (QCM-D measurement) on the QCM sensor surface-treated with the coating film forming compositions of Examples 1 and Comparative Examples 1 and 2 evaluated in Test Example 2 are obtained by measuring the mass per unit area. It is shown in a time-dependent graph.
- the results of the protein adhesion test (QCM-D measurement) on the QCM sensor surface-treated with the coating film forming composition of Example 2 evaluated in Test Example 4 are shown in a graph of time dependence of mass per unit area. It is a thing.
- the phosphate group-containing polymer of the present invention is a polymer (P) containing a hydroxy group, and the hydroxy group is a polymer (P) derived only from a phosphoric acid group.
- composition containing a copolymer obtained by polymerizing a monomer containing a phosphoric acid group and a monomer containing a hydroxy group other than the phosphoric acid group is already known
- the composition containing the phosphoric acid group of the present invention is already known.
- the hydroxy group of the polymer is derived only from the phosphate group.
- the hydroxy group derived from the phosphoric acid group causes a cross-linking reaction between the phosphoric acid group-containing polymers via the polycarbodiimide (C) described in detail below, resulting in excellent durability (water resistance) to a water-containing solvent or the like. It becomes a coating film.
- the coating film-forming composition of the present invention comprises the polymer (P) and The following formula (c-1): Polycarbodiimide (C) containing the structure represented by Includes solvent, and. The solvent and polycarbodiimide (C) will be described later.
- the polymer (P) is the formula (a) or the formula (a-1): [In the formula (a), U a1 and U a2 each independently represent a hydrogen atom or an alkyl group having 1 to 5 carbon atoms, and at least one of U a1 and U a 2 is a hydrogen atom.
- A represents an alkali metal.
- the structure represented by the formula (a) or the formula (a-1) is provided in the side chain with respect to the polymer main chain.
- the structure represented by the formula (a) or the formula (a-1) is included in the repeating unit structure of the polymer.
- alkyl group having 1 to 5 carbon atoms examples include a methyl group, an ethyl group, an n-propyl group, an isopropyl group, an n-butyl group, an isobutyl group, an s-butyl group, a t-butyl group and an n-pentyl group.
- Examples thereof include 1-methylbutyl group, 2-methylbutyl group, 3-methylbutyl group, 1,1-dimethylpropyl group, 1,2-dimethylpropyl group, 2,2-dimethylpropyl group or 1-ethylpropyl group.
- U a1 and U a2 are preferably a methyl group or an ethyl group.
- alkali metal examples include lithium, sodium, potassium, rubidium, cesium and francium, but sodium or potassium is preferable.
- Examples of the polymer (P) include polymers of the following compounds. Specific examples of the compound include acidphosphooxyethyl methacrylate, vinylphosphonic acid, acidphosphooxyethyl acrylate, 3-chloro-2-acidphosphooxypropyl methacrylate, acidphosphooxypropyl methacrylate, acidphosphooxymethylmethacrylate, and acidphosphooki. Examples thereof include polyoxyethylene glycol monomethacrylate and acid phosphooxypolyoxypropylene glycol monomethacrylate. Commercially available products may be used. Examples of commercially available products include Hosmer M (manufactured by Unichemical Co., Ltd.), PPM-5P (manufactured by Toho Chemical Industry Co., Ltd.), and the like.
- the polymer (P) has the formula (1): [In the formula, R 11 represents a hydrogen atom or an alkyl group having 1 to 5 carbon atoms, X 1 represents an alkylene group having 1 to 5 carbon atoms, and n1 represents an integer of 1 to 10. T 1 preferably contains a unit structure represented by the above formula (a) or the group of the formula (a-1)].
- the alkyl group having 1 to 5 carbon atoms is the same as that described above.
- a hydrogen atom or a methyl group is preferable as R 11.
- Examples of the alkylene group having 1 to 5 carbon atoms include a methylene group, an ethylene group, a propylene group, a trimethylene group, a tetramethylene group, a 1-methylpropylene group, a 2-methylpropylene group, a dimethylethylene group, an ethylethylene group and a penta.
- Methylene group 1-methyl-tetramethylene group, 2-methyl-tetramethylene group, 1,1-dimethyl-trimethylene group, 1,2-dimethyl-trimethylene group, 2,2-dimethyl-trimethylene group, 1-ethyl- Examples thereof include a trimethylene group.
- X 1 is preferably selected from an ethylene group and a propylene group.
- n1 an integer of 1 to 6 is preferable.
- the polymer (P) has the formula (1-1):
- R 11 , X 1 , n1 and T 1 can be obtained by polymerizing the compound represented by the above formula (1) by a known method.
- the polymer (P) according to the present invention may be copolymerized with any monomer as long as the desired performance of the coating film of the present invention is not impaired. Even in any monomer, the hydroxy group is derived only from the phosphoric acid group.
- formula (2-1) or (3-1) As an example of such a monomer, formula (2-1) or (3-1) :.
- R 12 and R 13 independently represent a hydrogen atom or an alkyl group having 1 to 5 carbon atoms
- X 2 and X 3 independently represent an alkylene group having 1 to 5 carbon atoms.
- T 2 is the following equation (b): (In the formula, U b1 , U b2 and U b3 independently represent a hydrogen atom or an alkyl group having 1 to 5 carbon atoms, and An ⁇ is a halide ion, an inorganic acid ion, a hydroxide ion and Represents an anion selected from the group consisting of isothiocyanate ions)
- T 3 represents an alkyl group having 1 to 18 carbon atoms, a cyclic hydrocarbon group having 3 to 10 carbon atoms, an aryl group having 6 to 10 carbon atoms, and an aralkyl group having 7 to 14 carbon atoms.
- a compound represented by a group or an aryloxyalkyl group having 7 to 14 carbon atoms] can be mentioned.
- Specific examples of the compound of the above formula (2-1) include dimethylaminoethyl (meth) acrylate, diethylaminoethyl (meth) acrylate, dimethylaminopropyl (meth) acrylate, and 2- (t-butylamino) ethyl (meth). Examples thereof include acrylate and metachlorocholine chloride.
- Specific examples of the compound (3-1) include linear or linear (meth) acrylic acids such as butyl (meth) acrylate, 2-ethylhexyl (meth) acrylate, lauryl (meth) acrylate, and stearyl (meth) acrylate.
- Cyclic alkyl esters of (meth) acrylic acids such as cyclohexyl (meth) acrylates and isobornyl (meth) acrylates
- Aralkyl esters of (meth) acrylic acids such as benzyl (meth) acrylates and phenethyl (meth) acrylates.
- Examples of any other monomer are ethylene glycol di (meth) acrylate, triethylene glycol di (meth) acrylate, propylene glycol di (meth) acrylate, bis phosphate (methacryloyloxymethyl), bis phosphate [2- ( A (meth) acrylate compound having two or more functional groups such as [methacryloyloxy) ethyl], bis (methacryloyloxy) propyl phosphate [2- (methacryloyloxy) propyl], and phosphinylidinetris triacrylate (oxy-2,1-ethandyl) Can be mentioned.
- a (meth) acrylate compound having two or more functional groups such as [methacryloyloxy) ethyl], bis (methacryloyloxy) propyl phosphate [2- (methacryloyloxy) propyl]
- phosphinylidinetris triacrylate oxy-2,1-ethandyl
- the weight average molecular weight of the polymer (P) according to the present invention may be about several thousand to several million, preferably 5,000 to 5,000,000. More preferably, it is 10,000 to 2,000,000.
- the weight average molecular weight can be measured by, for example, the Gel Filtration Chromatography described in Examples.
- the copolymer may be a random copolymer, a block copolymer, or a graft copolymer, and the copolymer for producing the copolymer may be used.
- the polymerization reaction itself is not particularly limited, and a method synthesized in a known solution such as radical polymerization, ionic polymerization, photopolymerization, macromer, and polymerization using emulsion polymerization can be used.
- the coating film-forming composition of the present invention may contain any one of the polymers (P) alone, or a plurality of polymers (P) may be mixed and the ratio thereof may be changed, depending on the intended use. May be included.
- Solvents contained in the coating film forming composition of the present invention include water, phosphate buffered saline (PBS) and alcohol.
- Alcohols include alcohols having 2 to 6 carbon atoms, such as ethanol, propanol, isopropanol, 1-butanol, 2-butanol, isobutanol, t-butanol, 1-pentanol, 2-pentanol, 3-pentanol.
- a pH adjuster may be contained in order to adjust the ion balance in the coating film forming composition according to the present invention. For example, it is carried out by adding a pH adjuster to the composition containing the copolymer and the solvent and setting the pH of the composition to 3.5 to 8.5, more preferably 4.0 to 8.0. May be good.
- the type and amount of the pH adjuster that can be used are appropriately selected depending on the concentration of the copolymer, the abundance ratio of the anion and the cation, and the like.
- pH adjusters include organic amines such as ammonia, diethanolamine, pyridine, N-methyl-D-glucamine, and tris (hydroxymethyl) aminomethane; alkali metal hydroxides such as potassium hydroxide and sodium hydroxide; chloride. Alkaline metal halides such as potassium and sodium chloride; inorganic acids such as sulfuric acid, phosphoric acid, hydrochloric acid and carbonic acid or alkali metal salts thereof; quaternary ammonium cations such as choline or mixtures thereof (eg, phosphate buffered physiological saline). And the like buffer solution). Among these, inorganic acids such as sulfuric acid, phosphoric acid, hydrochloric acid and carbonic acid are preferable.
- the polycarbodiimide (C) of the present invention has the following formula (c-1): Includes the structure represented by.
- the polycarbodiimide (C) of the present invention may be a polycarbodiimide compound derived from an aliphatic diisocyanate compound having at least one primary isocyanate group.
- the polycarbodiimide compound may have a structure in which all terminals are sealed with an organic compound having a functional group that reacts with an isocyanate group.
- the aliphatic diisocyanate compound having at least one primary isocyanate group is a chain-type aliphatic diisocyanate compound such as ethylene diisocyanate, tetramethylene diisocyanate, hexamethylene diisocyanate, and 2,2,4-trimethylhexamethylene diisocyanate.
- a chain-type aliphatic diisocyanate compound such as ethylene diisocyanate, tetramethylene diisocyanate, hexamethylene diisocyanate, and 2,2,4-trimethylhexamethylene diisocyanate.
- At least selected from the group consisting of cyclic aliphatic diisocyanate compounds such as isophorone diisocyanate, 1,3-bis (isocyanatomethyl) cyclohexane, norbornan diisocyanate, and aliphatic diisocyanate compounds having an aromatic ring such as xylylene diisocyanate. It may be one kind.
- the polycarbodiimide (C) of the present invention is obtained, for example, by a condensation reaction involving decarbonization of the aliphatic diisocyanate compound having at least one primary isocyanate group, and has at least two of the above formulas (c) in the molecule. It may be an isocyanate-terminated polycarbodiimide having a carbodiimide group represented by -1), or it may be a polycarbodiimide having a structure in which the terminal thereof is sealed with an organic compound having a functional group that reacts with the isocyanate group. ..
- the functional group of the organic compound may be at least one selected from a hydroxy group, an amino group, an isocyanate group, an epoxy group, and a carboxy group.
- organic compound examples include polyethylene glycol monomethyl ether, polyethylene glycol monoethyl ether, polypropylene glycol monomethyl ether, polypropylene glycol monoethyl ether, triethylene glycol monomethyl ether, triethylene glycol monoethyl ether, tetraethylene glycol monomethyl ether, and tetra.
- Organic compounds with hydroxy groups such as ethylene glycol monoethyl ether, diethylene glycol monomethyl ether, diethylene glycol monoethyl ether, ethyl alcohol, propyl alcohol, butyl alcohol, pentyl alcohol, hexyl alcohol, octyl alcohol, dodecyl alcohol; methylamine, ethylamine, propyl Amine, butylamine, pentylamine, hexylamine, octylamine, dodecylamine, diethylamine, dipropylamine, dibutylamine, cyclohexylamine, adamantanamine, allylamine, polyoxyethylene laurylamine, polyoxymethylenestearylamine, aniline, diphenylamine, 3 -Aminopropyltrimethoxysilane, 3-aminopropyltriethoxysilane, N-phenyl-3-aminopropyltrimethoxysilane,
- Organic compounds with epoxy groups acetic acid, ethanoic acid, propionic acid, butanoic acid, pentanic acid, hexane acid, heptanoic acid, octanoic acid, nonanoic acid, decanoic acid, cyclohexanecarboxylic acid, adamantan acetic acid, phenylacetic acid, benzoic acid.
- Organic compounds having a carboxy group such as undecenoic acid and derivatives thereof.
- the organic compound may have a hydrophilic group in addition to the functional group.
- the polycarbodiimide (C) contains a hydrophilic group.
- the hydrophilic group has the following formula (I): (In the formula, R 1 represents an alkyl group having a carbon number of 1 ⁇ 5, R 2 represents a hydrogen atom or a methyl group, if R 2 there are a plurality, said R 2 is either the same or different from each other M may represent an integer of 1 to 30).
- R 1 represents an alkyl group having a carbon number of 1 ⁇ 5
- R 2 represents a hydrogen atom or a methyl group, if R 2 there are a plurality, said R 2 is either the same or different from each other M may represent an integer of 1 to 30).
- the alkyl group having 1 to 5 carbon atoms is as described above.
- Examples of the organic compound having a hydrophilic group, particularly a hydrophilic group represented by the above formula (I), together with a functional group that reacts with an isocyanate group include polyethylene glycol monomethyl ether (MPEG) and tetraethylene glycol monomethyl ether (MTEMG). ), Etc., which may be used alone or in combination of two or more.
- MPEG polyethylene glycol monomethyl ether
- MTEMG tetraethylene glycol monomethyl ether
- Etc. which may be used alone or in combination of two or more.
- polycarbodiimide (C) As the polycarbodiimide (C), the polycarbodiimide compound described in International Publication No. 2018/194102 can be used. Other details of the polycarbodiimide compound of the present invention are in accordance with the contents described in International Publication No. 2018/194102.
- polycarbodiimide (C) As the polycarbodiimide (C), a commercially available product may be used. Commercially available product names include, for example, “Carbodilite V-02”, “Carbodilite V-02-L2", “Carbodilite V-04”, “Carbodilite E-01”, and “Carbodilite E-02” (all of which are Nisshinbo Chemicals). (Product name, manufactured by Co., Ltd.) can be mentioned.
- the coating film forming composition is applied to at least a part of the surface of a substrate such as a substrate.
- the coating method is not particularly limited, and ordinary spin coating, dip coating, solvent casting and other coating methods are used.
- the shape of the substrate is not particularly limited, and any of flat plate, curved surface, uneven shape, etc. can be used.
- the step of drying the coating film according to the present invention is carried out under the atmosphere or vacuum, preferably in the temperature range of ⁇ 200 ° C. to 200 ° C.
- the solvent in the coating film forming composition is removed, and a cross-linking reaction is caused to become a cured product, so that the coating film adheres to the substrate.
- the coating film can be formed by drying at room temperature (10 ° C. to 35 ° C., for example, 25 ° C.), for example, but in order to form the coating film more quickly, it is dried at, for example, 40 ° C. to 50 ° C. May be good. Further, a drying step at an extremely low temperature to a low temperature (around ⁇ 200 ° C. to ⁇ 30 ° C.) by a freeze-drying method may be used. Freeze-drying is called vacuum freeze-drying, which is a method of cooling what is normally desired to be dried with a refrigerant and removing the solvent by sublimation in a vacuum state. Common refrigerants used in freeze-drying include a mixed medium of dry ice and methanol (-78 ° C), liquid nitrogen (-196 ° C), and the like.
- drying temperature is less than -200 ° C, it is necessary to use an uncommon refrigerant, which lacks versatility, and it takes a long time to dry due to solvent sublimation, resulting in inefficiency. If the drying temperature is more than 200 ° C., the ionic bonding reaction on the surface of the coating film proceeds too much, the surface loses its hydrophilicity, and the ability to suppress the adhesion of biological substances is not exhibited.
- a more preferable drying temperature is 10 ° C. to 180 ° C., and a more preferable drying temperature is 25 ° C. to 150 ° C.
- the phosphate group-containing polymers of the present invention undergo a cross-linking reaction via the polycarbodiimide compound, for example, as shown in the above reaction formula, and become a cured product, whereby a coating film can be formed.
- the coating film of the present invention has durability against the above ⁇ solvent> in addition to water.
- the coating film of the present invention is effective for use when it is constantly exposed to a solvent containing water.
- One or more solvents selected from an aqueous solution containing water and an electrolyte to eliminate impurities, unreacted monomers, etc. remaining on the coating film after drying, and to adjust the ion balance of the polymer in the film. It is desirable to wash with running water or ultrasonic washing.
- the aqueous solution containing water and an electrolyte may be heated in the range of, for example, 40 ° C to 95 ° C.
- the aqueous solution containing an electrolyte PBS, physiological saline (containing only sodium chloride), dalbecolinic acid buffered saline, Tris buffered saline, HEEPS buffered saline and Veronal buffered saline are preferable, and PBS is preferable. Especially preferable.
- the coating film does not elute and remains firmly fixed to the substrate even when washed with water, PBS, alcohol, or the like. Even if the formed coating film adheres to the biological substance, it can be easily removed by washing with water or the like, and the surface of the substrate on which the coating film of the present invention is formed has an ability to suppress the adhesion of the biological substance.
- the film thickness of the coating film of the present invention is 10 to 1000 ⁇ , more preferably 10 to 500 ⁇ , and most preferably 20 to 400 ⁇ .
- the material of the substrate examples include glass, a metal-containing compound, a metalloid-containing compound, and a resin, but glass or a resin is preferably used from the viewpoint of versatility.
- the metal-containing compound or semi-metal-containing compound is, for example, a ceramic whose basic component is a metal oxide and is a sintered body baked and hardened by heat treatment at a high temperature, a semiconductor such as silicon, a metal oxide or a semi-metal oxide (silicon).
- the resin may be a natural resin or a derivative thereof, or a synthetic resin, and the natural resin or a derivative thereof may be synthetic such as cellulose, cellulose triacetate (CTA), nitrocellulose (NC), and cellulose immobilized with dextran sulfate.
- Resins include polyacrylonitrile (PAN), polyimide (PI), polyester polymer alloy (PEPA), polystyrene (PS), polysulfone (PSF), polyethylene terephthalate (PET), polymethylmethacrylate (PMMA), polyvinyl alcohol (PVA).
- PU Polyurethane
- EVAL Ethylene Vinyl Alcohol
- PE Polyethylene
- PP Polypropylene
- PVDF Polyfluorovinylidene
- PES Polyethersulfone
- PC Polycarbonate
- COP Cycloolefin Polymer
- PVC Polyvinyl chloride
- PTFE Polytetrafluoroethylene
- UHPE Ultrahigh molecular weight polyethylene
- PDMS Polydimethylsiloxane
- ABS Acrylonitrile-butadiene-styrene resin
- Teflon® Teflon®
- the coating film of the present invention is preferably a coating film having an ability to suppress adhesion of biological substances.
- examples of biological substances include proteins, sugars, viruses, nucleic acids and cells or combinations thereof.
- protein examples include fibrinogen, bovine serum albumin (BSA), human albumin, various globulin, ⁇ -lipoprotein, various antibodies (IgG, IgA, IgM), peroxidase, various complements, various lectins, fibronectin, lysoteam, and von Willebrand.
- BSA bovine serum albumin
- human albumin various globulin
- ⁇ -lipoprotein various antibodies (IgG, IgA, IgM)
- IgG, IgA, IgM antibodies
- peroxidase various complements
- various lectins fibronectin
- lysoteam lysoteam
- von Willebrand examples include fibrinogen, bovine serum albumin (BSA), human albumin, various globulin, ⁇ -lipoprotein, various antibodies (IgG, IgA, IgM), peroxidase, various complements, various lectins, fibronectin, lysoteam, and von Will
- vWF Brand factor
- sugars include glucose, galactose, mannose, fructose, heparin, hyaluronic acid,
- DNA deoxyribonucleic acid
- RNA ribonucleic acid
- the cells include fibroblasts, bone marrow cells, B lymphocytes, T lymphocytes, neutrophils, erythrocytes, platelets, macrophages, monospheres, bone cells, pericutaneous cells, dendritic cells, keratinocytes, fat cells, and mesenchymal cells.
- Cells epithelial cells, epidermal cells, endothelial cells, vascular endothelial cells, hepatic parenchymal cells, cartilage cells, oval cells, nervous system cells, glia cells, neurons, oligodendrocytes, microglia, stellate glue cells, heart cells, Esophageal cells, muscle cells (eg, smooth muscle cells or skeletal muscle cells), pancreatic beta cells, melanin cells, hematopoietic precursor cells, mononuclear cells, embryonic stem cells (ES cells), embryonic tumor cells, embryonic reproductive stem cells, Artificial pluripotent stem cells (iPS cells), nerve stem cells, hematopoietic stem cells, mesenchymal stem cells, hepatic stem cells, pancreatic stem cells, muscle stem cells, germ stem cells, intestinal stem cells, cancer stem cells, hair follicle stem cells, and various cell lines (eg,) HCT116, Huh7, HEK293 (human fetal kidney cell), HeLa (human cervical
- the coating film of the present invention has an excellent ability to suppress adhesion to sugars, proteins and nucleic acids, which are so-called biopolymers.
- the ability to suppress protein adhesion is defined as the mass (%) per unit area relative to the case without a coating film in the QCM-D measurement performed by the method described in Examples ((Example). (Mass per unit area (ng / cm 2 ) / (mass per unit area without coating film (ng / cm 2 ))) is 50% or less, preferably 30% or less, more preferably 20% or less. Means that; In the present invention, the ability to suppress cell adhesion is defined as the relative absorbance (WSTOD 450 nm) (%) when compared with no coating film by a fluorescence microscope performed by the method described in International Publication No. 2016/093293.
- the biological substance is selected from proteins or nucleic acids.
- the weight average molecular weight of the copolymer shown in the following synthesis example is a measurement result by Gel Filtration Chromatography (hereinafter abbreviated as GFC) or Gel Permeation Chromatography (hereinafter abbreviated as GPC).
- GFC Gel Filtration Chromatography
- GPC Gel Permeation Chromatography
- ⁇ GFC measurement conditions > ⁇ Equipment: Prominence (manufactured by Shimadzu Corporation) ⁇ GFC column: TSKgel GMPWXL (7.8 mm ID ⁇ 30 cm) ⁇ 2 to 3 ⁇ Flow rate: 1.0 mL / min ⁇ Eluent: Aqueous solution containing ionic substances or mixed solution of EtOH ⁇ Column temperature: 40 °C ⁇ Detector: RI -Injection concentration: Polymer solid content 0.05-0.5% by mass ⁇ Injection amount: 100uL ⁇ Calibration curve: cubic approximation curve ⁇ Standard sample: Polyethylene oxide (manufactured by Agilent) x 10 types ⁇ Measurement method of raw material composition> The concentration (mass%) of each phosphorus-containing compound in the raw material containing the phosphorus-containing compound was measured by 31 P-NMR. The absolute concentration (absolute mass%) of each phosphorus-containing compound contained in the raw material was calculated using the following standard substances.
- a mixture was prepared by stirring. The inside of the flask was replaced with nitrogen, and the temperature was raised to the reflux temperature with stirring.
- a polymer (P-2) -containing varnish having a solid content of about 19.9% by mass was obtained by heating and stirring while maintaining the above environment for 24 hours.
- the weight average molecular weight of the obtained liquid in GFC was about 150,000.
- Example 1 To 4 g of the polymer (P-1) -containing varnish obtained in Synthesis Example 1, 0.38 g of 1 mol / L hydrochloric acid (1N) (manufactured by Kanto Chemical Co., Ltd.) and 13.9 g of pure water were added and sufficiently stirred. do. To this, 0.18 g of Carbodilite V-02 (manufactured by Nisshinbo Chemical Co., Ltd., solid content of about 40% by mass) is added, and the mixture is stirred until uniform. Then, 17.81 g of ethanol was added and the mixture was sufficiently stirred to prepare a coating film-forming composition. The pH was 7.5.
- the obtained coating film-forming composition was spin-coated on a commercially available silicon wafer for semiconductor evaluation at 1500 rpm for 60 seconds, and dried in an oven at 70 ° C. for 24 hours. Then, it was thoroughly washed with PBS and pure water to obtain a silicon wafer on which a coating film was formed. When the film thickness of the coating film of the silicon wafer was confirmed with an optical interference film thickness meter, it was 171 ⁇ .
- Example 2 To 2 g of the polymer (P-2) -containing varnish obtained in Synthesis Example 2, 11.58 g of ethanol, 21.35 g of pure water, and 5.26 g of 1N aqueous ammonia (manufactured by Kanto Chemical Co., Inc.) are sufficiently added. Stirred. A coating film-forming composition was prepared by adding 1.50 g of a solution of Carbodilite V-02 (manufactured by Nisshinbo Chemical Co., Ltd., solid content of about 40% by mass) diluted 10-fold with pure water and stirring sufficiently. The pH was 9.9.
- the obtained coating film-forming composition was spin-coated on an HMDS-treated silicon wafer at 1500 rpm / 60 sec and dried at 50 ° C. for 3 hours. Then, it was thoroughly washed with PBS and pure water and then dried at 70 ° C. for 1 hour to obtain a coating film on the HMDS-treated silicon wafer.
- the film thickness of the coating film on the HMDS-treated silicon wafer was confirmed with a spectroscopic ellipsometer, it was 227 ⁇ .
- a commercially available silicone coating agent Siliconize L-25 (manufactured by Fuji Systems Co., Ltd.)
- ⁇ Creation of surface-treated QCM sensor> The coating film-forming compositions of Examples 1 and 2 and Comparative Example 1 were spin-coated on a QCM sensor (PS) at 3500 rpm / 30 seconds, respectively, and baked in an oven at 70 ° C. for 24 hours as a drying step. Then, as a cleaning step, the excessively applied uncured coating film forming composition is washed twice with PBS and ultrapure water, and each sensor is immersed in PBS and washed with ultrasonic waves for 5 minutes. , A surface-treated QCM sensor was obtained with the coating film forming compositions of Examples 1 and 2 and Comparative Example 1. For the coating film forming composition of Comparative Example 2, a surface-treated QCM sensor was obtained by the same method except that it was baked at 150 ° C./30 minutes in the drying step.
- Table 1 shows the amount of protein adsorbed in terms of the mass (ng / cm 2 ) of the above, and FIG. 1 shows a graph of the time dependence of the mass per unit area.
- the surface-treated QCM sensor (Example 1) using the coating film-forming composition according to the present invention includes a surface-treated QCM sensor (Comparative Examples 1 and 2) using the coating film-forming composition of Comparative Example and a PS sensor without a coating film. The amount of protein adhered was remarkably low.
- Test Example 2 ⁇ DNA adhesion test; QCM-D measurement>
- Each QCM sensor surface-treated with the coating film-forming compositions of Examples 1 and Comparative Examples 1 and 2 prepared in the same manner as in Test Example 1 is dissipated from the dissipative quartz crystal microbalance QCM-D (E4, It was attached to Q-Sense (manufactured by Biolin Scientific), and PBS was run until a stable baseline was established in which the frequency change was 1 Hz or less in 1 hour. Next, PBS was run for about 10 minutes with a stable baseline frequency of 0 Hz.
- Table 2 shows the amount of DNA adsorbed in terms of the mass (ng / cm 2 ) of the above, and FIG. 2 shows a graph of the time dependence of the mass per unit area.
- the QCM sensor surface-treated with the coating film-forming composition according to the present invention includes a surface-treated QCM sensor (Comparative Examples 1 and 2) with the coating film-forming composition of Comparative Example and a PS sensor without a coating film. The amount of DNA adhered was remarkably low.
- Example 3 ⁇ DNA adsorption suppression test; fluorescence intensity measurement>
- the coating film-forming composition of Example 1 and the coating film-forming composition of Comparative Example 1 were placed in a 1.5 mL tube (manufactured by Thermo Fisher Scientific) made of polypropylene (PP) at 150 ⁇ L / tube, and the whole amount was dried at 50 ° C. Then, it was thoroughly washed with pure water to obtain a PP 1.5 mL tube on which a coating film was formed.
- PP polypropylene
- Human Genomic DNA (TAKARA BIO INC.) was prepared at 2 ng / ⁇ L using 10 mM Tris-EDTA buffer (pH 7.4) (Fuji Film Wako Pure Chemical Industries, Ltd.) supplemented with 0.1 M NaCl. , 100 ⁇ L was placed in a 1.5 mL tube made of PP on which a coating film was formed. As a control, Human Genomic DNA was similarly added to a PP 1.5 mL tube (non-coated tube) having no coated film. Each tube was stored at 40 ° C. for 7 days.
- the Human Generic DNA solution was recovered, and 95 ⁇ L of QuantiFluor® ONE dsDNA System (manufactured by Promega) was added to 5 ⁇ L of the DNA solution on a polystyrene black microplate (manufactured by Corning). Using an Enspire multi-mode plate reader (manufactured by PerkinElmer), Ex. 504 nm, Em. The DNA concentration was calculated by measuring 531 nm.
- Table 3 shows the concentration of Human Genomic DNA that remained without adhering to the tube after being stored in each tube.
- Test Example 4 ⁇ Protein adhesion test; QCM-D measurement>
- a QCM sensor surface-treated with the coating film-forming composition of Example 2 prepared by the same method as in Test Example 1 is dissipated quartz crystal microbalance QCM-D (E4, Q-Sense, manufactured by Biolin Scientific).
- the PBS was run for 100 hours. Next, PBS was run for about 10 minutes with a stable baseline frequency of 0 Hz.
- Table 4 shows the amount of protein adsorbed in terms of the mass (ng / cm 2 ) of the above, and FIG. 3 shows a graph of the time dependence of the mass per unit area.
- the QCM sensor surface-treated with the coating film-forming composition according to the present invention (Example 2) showed a significantly lower protein adhesion as compared with the PS sensor without the coating film.
- the coating film forming composition containing the phosphate group-containing polymer of the present invention provides a coating film having excellent durability against a solvent containing water, a coating film having an ability to suppress adhesion of biological substances, and a protein. And a coating film having an excellent ability to suppress adhesion to nucleic acids can be provided.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Wood Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Paints Or Removers (AREA)
- Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
Abstract
Description
ヒドロキシ基を含有する重合体(P)であって、該ヒドロキシ基はリン酸基由来のみである重合体(P)と、
下記式(c-1):
で表される構造を含むポリカルボジイミド(C)と、
溶媒、とを含む、コーティング膜形成組成物。
前記重合体(P)が、式(a)又は式(a-1):
[式(a)中、Ua1及びUa2は、それぞれ独立して、水素原子又は炭素原子数1~5のアルキル基を表し、Ua1及びUa2の少なくとも1つは水素原子であり、式(a-1)中、Aは、アルカリ金属を表す]で表される基を含む、[1]に記載のコーティング膜形成組成物。
前記重合体(P)が、式(1):
[式中、R11は、水素原子又は炭素原子数1~5のアルキル基を表し、X1は、炭素原子数1~5のアルキレン基を表し、n1は、1~10の整数を表し、T1は、前記式(a)又は式(a-1)の基を表す]で表される単位構造を含む、[1]又は[2]に記載のコーティング膜形成組成物。
前記ポリカルボジイミド(C)が、親水性基を含む、[1]~[3]何れか1項に記載のコーティング膜形成組成物。
前記親水性基が、下記式(I):
(式中、R1は、炭素原子数1~5のアルキル基を表し、R2は、水素原子又はメチル基を表すが、R2が複数存在する場合、該R2は互いに同一でも異なっていてもよく、mは、1~30の整数を表す)で表される、[4]に記載のコーティング膜形成組成物。
生体物質の付着抑制能を有するコーティング膜形成用である、請求項1~5何れか1項に記載のコーティング膜形成組成物。
前記生体物質が、生体高分子である、[6]に記載のコーティング膜形成組成物。
[1]~[7]何れか1項に記載のコーティング膜形成組成物の塗布膜の硬化物である、コーティング膜。
[1]~[7]何れか1項に記載のコーティング膜形成組成物を基体に塗布する工程を含む、コーティング膜の製造方法。
本発明のリン酸基含有ポリマーは、ヒドロキシ基を含有する重合体(P)であって、該ヒドロキシ基はリン酸基由来のみである重合体(P)、であることを特徴とする。
[式(a)中、Ua1及びUa2は、それぞれ独立して、水素原子又は炭素原子数1~5のアルキル基を表し、Ua1及びUa2の少なくとも1つは水素原子である。式(a-1)中、Aはアルカリ金属を表す。]で表される基を含むことが好ましい。
[式中、R11は、水素原子又は炭素原子数1~5のアルキル基を表し、X1は、炭素原子数1~5のアルキレン基を表し、n1は、1~10の整数を表し、T1は、前記式(a)又は式(a-1)の基を表す]で表される単位構造を含むことが好ましい。
前記炭素原子数1~5のアルキレン基としては、メチレン基、エチレン基、プロピレン基、トリメチレン基、テトラメチレン基、1-メチルプロピレン基、2-メチルプロピレン基、ジメチルエチレン基、エチルエチレン基、ペンタメチレン基、1-メチル-テトラメチレン基、2-メチル-テトラメチレン基、1,1-ジメチル-トリメチレン基、1,2-ジメチル-トリメチレン基、2,2-ジメチル-トリメチレン基、1-エチル-トリメチレン基等が挙げられる。これらの中で、X1としてはエチレン基及びプロピレン基から選ばれることが好ましい。
n1としては1~6の整数が好ましい。
[式中、R12及びR13は、独立して、水素原子又は炭素原子数1~5のアルキル基を表し、X2及びX3は、独立して、炭素原子数1~5のアルキレン基を表し、T2は、下記式(b):
(式中、Ub1、Ub2及びUb3は、独立して、水素原子又は炭素原子数1~5のアルキル基を表し、An-は、ハロゲン化物イオン、無機酸イオン、水酸化物イオン及びイソチオシアネートイオンからなる群から選ばれる陰イオンを表す)
の基を表し、T3は、炭素原子数1~18のアルキル基、炭素原子数3~10の環式炭化水素基、炭素原子数6~10のアリール基、炭素原子数7~14のアラルキル基又は炭素原子数7~14のアリールオキシアルキル基を表す]で表される化合物が挙げられる。
上記(3-1)の化合物の具体例としては、ブチル(メタ)アクリレート、2-エチルヘキシル(メタ)アクリレート、ラウリル(メタ)アクリレート、ステアリル(メタ)アクリレート等の(メタ)アクリル酸の直鎖若しくは分岐アルキルエステル類;シクロヘキシル(メタ)アクリレート、イソボルニル(メタ)アクリレート等の(メタ)アクリル酸の環状アルキルエステル類;ベンジル(メタ)アクリレート、フェネチル(メタ)アクリレート等の(メタ)アクリル酸のアラルキルエステル類が挙げられる。
本発明のコーティング膜形成組成物が含む溶媒は、水、リン酸緩衝生理食塩水(PBS)及びアルコールが挙げられる。アルコールとしては、炭素原子数2~6のアルコール、例えば、エタノール、プロパノール、イソプロパノール、1-ブタノール、2-ブタノール、イソブタノール、t-ブタノール、1-ペンタノール、2-ペンタノール、3-ペンタノール、1-ヘプタノール、2-ヘプタノール、2,2-ジメチル-1-プロパノール(ネオペンチルアルコール)、2-メチル-1-プロパノール、2-メチル-1-ブタノール、2-メチル-2-ブタノール(t-アミルアルコール)、3-メチル-1-ブタノール、3-メチル-3-ペンタノール、シクロペンタノール、1-ヘキサノール、2-ヘキサノール、3-ヘキサノール、2,3-ジメチル-2-ブタノール、3,3-ジメチル-1-ブタノール、3,3-ジメチル-2-ブタノール、2-エチル-1-ブタノール、2-メチル-1-ペンタノール、2-メチル-2-ペンタノール、2-メチル-3-ペンタノール、3-メチル-1-ペンタノール、3-メチル-2-ペンタノール、3-メチル-3-ペンタノール、4-メチル-1-ペンタノール、4-メチル-2-ペンタノール、4-メチル-3-ペンタノール及びシクロヘキサノールが挙げられ、単独で又はそれらの組み合わせの混合溶媒を用いてもよいが、リン酸含有ポリマーの溶解性の観点から、水、PBS及びエタノールから選ばれるのが好ましい。
前記ポリカルボジイミド化合物は、すべての末端に、イソシアネート基と反応する官能基を有する有機化合物で封止された構造を有していてもよい。
(式中、R1は、炭素原子数1~5のアルキル基を表し、R2は、水素原子又はメチル基を表すが、R2が複数存在する場合、該R2は互いに同一でも異なっていてもよく、mは、1~30の整数を表す)で表されることが好ましい。前記炭素原子数1~5のアルキル基としては、上述の通りである。
本発明のコーティング膜を形成すべく、前記のコーティング膜形成組成物を基板等の基体の表面の少なくとも一部に塗布する。塗布方法としては特に制限は無く、通常のスピンコート、ディップコート、溶媒キャスト法等の塗布法が用いられる。
本発明において、生体物質としては、タンパク質、糖、ウイルス、核酸及び細胞又はそれらの組み合わせが挙げられる。
例えば糖としてはグルコース、ガラクトース、マンノース、フルクトース、ヘパリン、ヒアルロン酸、
例えば核酸としてはデオキシリボ核酸(DNA)、リボ核酸(RNA)、
前記細胞としては線維芽細胞、骨髄細胞、Bリンパ球、Tリンパ球、好中球、赤血球、血小板、マクロファージ、単球、骨細胞、周皮細胞、樹枝状細胞、ケラチノサイト、脂肪細胞、間葉細胞、上皮細胞、表皮細胞、内皮細胞、血管内皮細胞、肝実質細胞、軟骨細胞、卵丘細胞、神経系細胞、グリア細胞、ニューロン、オリゴデンドロサイト、マイクログリア、星状膠細胞、心臓細胞、食道細胞、筋肉細胞(例えば、平滑筋細胞又は骨格筋細胞)、膵臓ベータ細胞、メラニン細胞、造血前駆細胞、単核細胞、胚性幹細胞(ES細胞)、胚性腫瘍細胞、胚性生殖幹細胞、人工多能性幹細胞(iPS細胞)、神経幹細胞、造血幹細胞、間葉系幹細胞、肝幹細胞、膵幹細胞、筋幹細胞、生殖幹細胞、腸幹細胞、癌幹細胞、毛包幹細胞、及び各種細胞株(例えば、HCT116、Huh7、HEK293(ヒト胎児腎細胞)、HeLa(ヒト子宮頸癌細胞株)、HepG2(ヒト肝癌細胞株)、UT7/TPO(ヒト白血病細胞株)、CHO(チャイニーズハムスター卵巣細胞株)、MDCK、MDBK、BHK、C-33A、HT-29、AE-1、3D9、Ns0/1、Jurkat、NIH3T3、PC12、S2、Sf9、Sf21、High Five、Vero)等が挙げられる。
本発明において、細胞の付着抑制能を有するとは、国際公開第2016/093293号に記載した方法で行う蛍光顕微鏡によるコーティング膜無しと比較した場合の相対吸光度(WST O.D.450nm)(%)((実施例の吸光度(WST O.D.450nm))/(比較例の吸光度(WST O.D.450nm)))が50%以下、好ましくは30%以下、さらに好ましくは20%以下であることを意味する。
・装置:Prominence((株)島津製作所製)
・GFCカラム:TSKgel GMPWXL(7.8mmI.D.×30cm)×2~3本
・流速:1.0mL/分
・溶離液:イオン性物質含有水溶液、もしくは、EtOHの混合溶液
・カラム温度:40℃
・検出器:RI
・注入濃度:ポリマー固形分0.05~0.5質量%
・注入量:100uL
・検量線:三次近似曲線
・標準試料:ポリエチレンオキサイド(Agilent社製)×10種
<原料組成の測定方法>
リン含有化合物を含む原料の、各リン含有化合物の濃度(質量%)測定は、31P-NMRにより行った。下記標準物質を用いて原料中に含まれる各リン含有化合物の絶対濃度(絶対質量%)を算出した。
・モード:逆ゲートデカップリングモード(定量モード)
・装置:varian 400 MHz
・溶媒:CD3OD(重メタノール)(30重量%)
・回転数:0Hz
・データポイント:64000
・フリップ角:90°
・待ち時間:70秒
・積算回数:16回、n=4
・標準物質: トリメチルリン酸+D2O (75%TMP溶液を調製)
アシッドホスホオキシエチルメタアクリレート(製品名;ホスマーM、ユニケミカル(株)製、乾固法100℃・1時間における不揮発分:91.8%、アシッドホスホオキシエチルメタクリレート(44.2質量%)、リン酸ビス[2-(メタクリロイルオキシ)エチル](28.6質量%)、その他の物質(27.2質量%)の混合物)10gを水冷して撹拌しながら5mol/L水酸化ナトリウム水溶液(5N)(関東化学(株)製)11.49gを滴下して35℃以下を維持しつつ中和する。そこに純水18.72gを投入し、2,2’-アゾビス(N-(2-カルボキシエチル)-2-メチルプロピオンアミジン)n-水和物(製品名;VA-057、富士フイルム和光純薬(株)製)0.05gを加えて35℃以下で十分に溶解させる。更にエタノール10.79gを加えて十分に撹拌して均一となった上記全てのものが入った混合液を、滴下ポンプを介した3つ口フラスコに導入した。一方で、別途純水68.86gを冷却管付きの3つ口フラスコに加えて窒素フローし、撹拌しながらリフラックス温度まで昇温した。この状態を維持しつつ、前記混合液をテフロンチューブで介した滴下ポンプにて、0.5時間かけて混合液を純水の沸騰液内に滴下した。滴下後、4時間上記環境を維持した状態で加熱撹拌する。4時間後に冷却することで固形分約9.26質量%の重合体(P-1)含有ワニス119.91gを得た。得られた液体のGFCにおける重量平均分子量は約290,000であった。
アシッドホスホオキシポリプロピレングリコールモノメタクリレート(プロピレンオキサイドの平均付加モル数5)(製品名:PPM-5P、東邦化学工業(株)製、絶対質量%(純度)97.3質量%)6.02g、メタクロイルコリンクロリド約80%水溶液(東京化成工業(株)製)2.54g、メタクリル酸ブチル(東京化成工業(株)製)4.15g、エタノール(純正化学(株)製)48.7g、及びジメチル-1,1′-アゾビス(1-シクロヘキサンカルボキシレート)(製品名:VE-073、富士フイルム和光純薬(株)製)32.3mgを冷却管付きの4つ口フラスコに加えて均一に撹拌し混合液を調製した。フラスコ内を窒素置換し、撹拌しながらリフラックス温度まで昇温した。24時間上記環境を維持した状態で加熱撹拌することで固形分約19.9質量%の重合体(P-2)含有ワニスを得た。得られた液体のGFCにおける重量平均分子量は約150,000であった。
上記合成例1で得られた重合体(P-1)含有ワニス4gに、1mol/L塩酸(1N)(関東化学(株)製)0.38gと純水13.9gを加えて十分に撹拌する。そこに、カルボジライト V-02(日清紡ケミカル(株)製、固形分約40質量%)0.18gを加え均一になるまで撹拌する。その後、エタノール17.81gを加えて十分に撹拌し、コーティング膜形成組成物を調製した。pHは7.5であった。得られたコーティング膜形成組成物を、半導体評価用の市販のシリコンウェハに1500rpmで60秒でスピンコートし、オーブンにて70℃、24時間乾燥させた。その後、PBSと純水で十分に洗浄を行って、コーティング膜が形成されたシリコンウェハを得た。光学式干渉膜厚計でシリコンウェハのコーティング膜の膜厚を確認したところ171Åであった。
上記合成例2で得られた重合体(P-2)含有ワニス2gに、エタノール11.58g、純水21.35g、1Nアンモニア水(関東化学(株)製)5.26gを加えて十分に撹拌した。そこにカルボジライト V-02(日清紡ケミカル(株)製、固形分約40質量%)を純水で10倍希釈した溶液を1.50g加え十分に撹拌することでコーティング膜形成組成物を調製した。pHは9.9であった。得られたコーティング膜形成組成物を1500rpm/60secでHMDS処理済シリコンウェハにスピンコートし、50℃で3時間乾燥した。その後、PBSと純水で十分に洗浄を行った後70℃で1時間乾燥し、HMDS処理済シリコンウェハ上にコーティング膜を得た。分光エリプソメーターでHMDS処理済シリコンウェハ上のコーティング膜の膜厚を確認したところ、227Åであった。
上記合成例1で得られた重合体(P)含有ワニス4gに、1mol/L塩酸(1N)(関東化学(株)製)0.38gと純水14.57gを加えて十分に撹拌する。その後、エタノール17.81gを記載の加えて十分に撹拌し、コーティング膜形成組成物を調製した。pHは7.5であった。得られたコーティング膜形成組成物を、半導体評価用の市販のシリコンウェハに1500rpmで60秒でスピンコートし、オーブンにて70℃、24時間乾燥させた。その後、PBSと純水で十分に洗浄を行って、コーティング膜が形成されたシリコンウェハを得た。光学式干渉膜厚計でシリコンウェハのコーティング膜の膜厚を確認したところ26Åであった。
市販のシリコーンコーティング剤であるシリコナイズL-25(富士システムズ(株)製)を1gに純水50gを加え十分に撹拌した。得られたコーティング膜形成組成物を、半導体評価用の市販のシリコンウェハに1500rpmで60秒でスピンコートし、オーブンにて150℃、0.5時間乾燥させた。その後、PBSと純水で十分に洗浄を行って、コーティング膜が形成されたシリコンウェハを得た。
<QCMセンサー(PS)の作成>
Au蒸着された水晶振動子(Q-Sense、QSX304、Biolin Scientific社製)を、UV/オゾン洗浄装置(UV253E、フィルジェン(株)製)を用いて3分間洗浄し、直後に2-アミノエタンチオール(東京化成工業(株)製)0.0772gをエタノール1000mLに溶解した溶液中に24時間浸漬した。エタノールでセンサー表面を洗浄後、自然乾燥し、ポリスチレン(Aldrich社製)1.00gをトルエン99.00gに溶解したワニスをスピンコーターにて3500rpm/30秒で膜センサー側にスピンコートし、120℃/1分乾燥することでQCMセンサー(PS)とした。
実施例1、2及び比較例1のコーティング膜形成組成物をそれぞれ、3500rpm/30秒でQCMセンサー(PS)にスピンコートし、乾燥工程として70℃のオーブンで24時間ベークした。その後、洗浄工程として過剰についた未硬化のコーティング膜形成組成物をPBSと超純水にて各2回ずつ洗浄し、更に、PBS中に各センサーを浸漬させ超音波で5分間洗浄することで、実施例1、2及び比較例1のコーティング膜形成組成物で表面処理済QCMセンサーを得た。比較例2のコーティング膜形成組成物は、乾燥工程に150℃/30分ベークする以外は同様の方法で表面処理済QCMセンサーを得た。
実施例1、並びに比較例1及び2のコーティング膜形成組成物で表面処理済の各QCMセンサーを、散逸型水晶振動子マイクロバランスQCM-D(E4、Q-Sense、Biolin Scientific社製)に取り付け、周波数の変化が1時間で1Hz以下となる安定したベースラインを確立するまでPBSを流した。次に、安定したベースラインの周波数を0Hzとして約10分間PBSを流した。引き続き、γ-グロブリンヒト血液由来(Aldrich社製)を100μg/mLでPBSにて希釈した溶液を約30分流し、その後再びPBSを約20分流した後の9次オーバートーンの吸着誘起周波数のシフト(Δf)を読み取った。対照としてコーティング膜無しのPSセンサーも同様の試験に付した。分析のためにQ-Tools(Q-Sense、Biolin Scientific社製)を使用して、吸着誘起周波数のシフト(Δf)を、Sauerbrey式で説明される吸着誘起周波数のシフト(Δf)を単位面積当たりの質量(ng/cm2)と換算したものをタンパク質の付着量として表1に、単位面積当たりの質量の時間依存性のグラフを図1に示す。本発明に係るコーティング膜形成組成物による表面処理済QCMセンサー(実施例1)は、比較例のコーティング膜形成組成物による表面処理済QCMセンサー(比較例1及び2)やコーティング膜無しのPSセンサーと比較し、著しく低いタンパク質付着量を示した。
<DNA付着試験;QCM-D測定>
試験例1と同様な方法にて作成した、実施例1、並びに比較例1及び2のコーティング膜形成組成物で表面処理済の各QCMセンサーを散逸型水晶振動子マイクロバランスQCM-D(E4、Q-Sense、Biolin Scientific社製)に取り付け、周波数の変化が1時間で1Hz以下となる安定したベースラインを確立するまでPBSを流した。次に、安定したベースラインの周波数を0Hzとして約10分間PBSを流した。引き続き、デオキシリボ核酸 ナトリウム塩 ヒト胎盤由来(Aldrich社製)を100μg/mLでPBSにて希釈した溶液を約30分流し、その後再びPBSを約20分流した後の9次オーバートーンの吸着誘起周波数のシフト(Δf)を読み取った。対照としてコーティング膜無しのPSセンサーも同様の試験に付した。分析のためにQ-Tools(Q-Sense、Biolin Scientific社製)を使用して、吸着誘起周波数のシフト(Δf)を、Sauerbrey式で説明される吸着誘起周波数のシフト(Δf)を単位面積当たりの質量(ng/cm2)と換算したものをDNAの付着量として表2に、単位面積当たりの質量の時間依存性のグラフを図2に示す。本発明に係るコーティング膜形成組成物で表面処理済QCMセンサー(実施例1)は、比較例のコーティング膜形成組成物による表面処理済QCMセンサー(比較例1及び2)やコーティング膜無しのPSセンサーと比較し、著しく低いDNA付着量を示した。
<DNA吸着抑制試験;蛍光強度測定>
実施例1のコーティング膜形成組成物及び比較例1のコーティング膜形成組成物をポリプロピレン(PP)製1.5mLチューブ(Thermo Fisher Scientific製)に150μL/チューブ入れ、50℃で全量乾燥させた。その後、純水で十分に洗浄を行ってコーティング膜が形成されたPP製1.5mLチューブを得た。続いて、Human Genomic DNA(TAKARA BIO INC.)を0.1M NaClを添加した10mM Tris-EDTA緩衝液(pH7.4)(富士フイルム和光純薬(株))を用いて2ng/μLに調製し、コーティング膜を形成したPP製1.5mLチューブに100μL入れた。対照としてコーティング膜を形成していないPP製1.5mLチューブ(非コーティングチューブ)に対してもHuman Genomic DNAを同様に入れた。各チューブは40℃で7日間保管した。保管後、Human Genomic DNA溶液を回収し、ポリスチレン製黒色マイクロプレート(Corning社製)上でDNA溶液5μLにQuantiFluor(登録商標)ONE dsDNA System(Promega社製)を95μL加えた。Enspireマルチモードプレートリーダー(PerkinElmer社製)を使用してEx.504nm、Em.531nmを測定しDNA濃度を算出した。
<タンパク質付着試験;QCM-D測定>
試験例1と同様な方法にて作成した、実施例2のコーティング膜形成組成物で表面処理済QCMセンサーを散逸型水晶振動子マイクロバランスQCM-D(E4、Q-Sense、Biolin Scientific社製)に取り付け、PBSを100時間流した。次に、安定したベースラインの周波数を0Hzとして約10分間PBSを流した。引き続き、γ-グロブリンヒト血液由来(Aldrich社製)を100μg/mLでPBSにて希釈した溶液を約30分流し、その後再びPBSを約20分流した後の9次オーバートーンの吸着誘起周波数のシフト(Δf)を読み取った。対照としてコーティング膜無しのPSセンサーも同様の試験に付した。分析のためにQ-Tools(Q-Sense、Biolin Scientific社製)を使用して、吸着誘起周波数のシフト(Δf)を、Sauerbrey式で説明される吸着誘起周波数のシフト(Δf)を単位面積当たりの質量(ng/cm2)と換算したものをタンパク質の付着量として表4に、単位面積当たりの質量の時間依存性のグラフを図3に示す。本発明に係るコーティング膜形成組成物で表面処理済QCMセンサー(実施例2)は、コーティング膜無しのPSセンサーと比較し、著しく低いタンパク質付着量を示した。
Claims (9)
- 前記ポリカルボジイミド(C)が、親水性基を含む、請求項1~3何れか1項に記載のコーティング膜形成組成物。
- 生体物質の付着抑制能を有するコーティング膜形成用である、請求項1~5何れか1項に記載のコーティング膜形成組成物。
- 前記生体物質が、生体高分子である、請求項6に記載のコーティング膜形成組成物。
- 請求項1~7何れか1項に記載のコーティング膜形成組成物の塗布膜の硬化物である、コーティング膜。
- 請求項1~7何れか1項に記載のコーティング膜形成組成物を基体に塗布する工程を含む、コーティング膜の製造方法。
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2022531928A JPWO2021256553A1 (ja) | 2020-06-19 | 2021-06-18 | |
CN202180043413.6A CN115698206B (zh) | 2020-06-19 | 2021-06-18 | 包含含磷酸基聚合物的涂覆膜形成组合物 |
US18/002,366 US20230235141A1 (en) | 2020-06-19 | 2021-06-18 | Composition for forming coating film containing phosphoric acid group-containing polymer |
EP21825606.3A EP4169991A4 (en) | 2020-06-19 | 2021-06-18 | COMPOSITION FOR COATING FILM FORMATION WITH A POLYMER CONTAINING PHOSPHATE GROUPS |
KR1020237000293A KR20230025427A (ko) | 2020-06-19 | 2021-06-18 | 인산기 함유 폴리머를 포함하는 코팅막 형성 조성물 |
AU2021291562A AU2021291562A1 (en) | 2020-06-19 | 2021-06-18 | Composition for forming coating film containing phosphoric acid group-containing polymer |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2020-105748 | 2020-06-19 | ||
JP2020105748 | 2020-06-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2021256553A1 true WO2021256553A1 (ja) | 2021-12-23 |
Family
ID=79268043
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2021/023144 WO2021256553A1 (ja) | 2020-06-19 | 2021-06-18 | リン酸基含有ポリマーを含むコーティング膜形成組成物 |
Country Status (8)
Country | Link |
---|---|
US (1) | US20230235141A1 (ja) |
EP (1) | EP4169991A4 (ja) |
JP (1) | JPWO2021256553A1 (ja) |
KR (1) | KR20230025427A (ja) |
CN (1) | CN115698206B (ja) |
AU (1) | AU2021291562A1 (ja) |
TW (1) | TW202214726A (ja) |
WO (1) | WO2021256553A1 (ja) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2023080165A1 (ja) * | 2021-11-02 | 2023-05-11 | 日産化学株式会社 | 生体物質付着抑制材 |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS61211372A (ja) * | 1985-03-15 | 1986-09-19 | Daicel Chem Ind Ltd | 電子部品用コ−テイング剤 |
JP2003026982A (ja) * | 2001-07-18 | 2003-01-29 | Toyo Ink Mfg Co Ltd | 水性印刷インキ組成物およびそれを用いた紙製包装材料ならびに包装容器 |
JP2010505969A (ja) | 2006-10-03 | 2010-02-25 | 関西ペイント株式会社 | 水性メタリック塗料組成物及び複層塗膜形成方法 |
WO2010119969A1 (ja) * | 2009-04-14 | 2010-10-21 | 関西ペイント株式会社 | ベースコート塗料組成物 |
WO2014196650A1 (ja) | 2013-06-07 | 2014-12-11 | 日産化学工業株式会社 | 生体物質の付着抑制能を有するイオンコンプレックス材料及びその製造方法 |
WO2016093293A1 (ja) | 2014-12-10 | 2016-06-16 | 日産化学工業株式会社 | 生体物質の付着抑制能を有するイオンコンプレックス材料及びその製造方法 |
WO2017131104A1 (ja) * | 2016-01-27 | 2017-08-03 | 日本ペイント・オートモーティブコーティングス株式会社 | プライマー塗料組成物および塗膜形成方法 |
WO2018194102A1 (ja) | 2017-04-21 | 2018-10-25 | 日清紡ケミカル株式会社 | ポリカルボジイミド化合物及びその製造方法、並びに樹脂組成物 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1371697A3 (en) * | 2002-06-14 | 2004-01-02 | Rohm And Haas Company | Polymeric binders for inkjet inks |
JP2017078090A (ja) * | 2014-03-03 | 2017-04-27 | 国立大学法人富山大学 | 生体物質の付着抑制能を有するイオンコンプレックス材料 |
US20190233792A1 (en) * | 2016-05-27 | 2019-08-01 | Nissan Chemical Corporation | Cell culture vessel |
-
2021
- 2021-06-18 AU AU2021291562A patent/AU2021291562A1/en active Pending
- 2021-06-18 EP EP21825606.3A patent/EP4169991A4/en active Pending
- 2021-06-18 TW TW110122370A patent/TW202214726A/zh unknown
- 2021-06-18 KR KR1020237000293A patent/KR20230025427A/ko unknown
- 2021-06-18 WO PCT/JP2021/023144 patent/WO2021256553A1/ja unknown
- 2021-06-18 JP JP2022531928A patent/JPWO2021256553A1/ja active Pending
- 2021-06-18 US US18/002,366 patent/US20230235141A1/en active Pending
- 2021-06-18 CN CN202180043413.6A patent/CN115698206B/zh active Active
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS61211372A (ja) * | 1985-03-15 | 1986-09-19 | Daicel Chem Ind Ltd | 電子部品用コ−テイング剤 |
JP2003026982A (ja) * | 2001-07-18 | 2003-01-29 | Toyo Ink Mfg Co Ltd | 水性印刷インキ組成物およびそれを用いた紙製包装材料ならびに包装容器 |
JP2010505969A (ja) | 2006-10-03 | 2010-02-25 | 関西ペイント株式会社 | 水性メタリック塗料組成物及び複層塗膜形成方法 |
WO2010119969A1 (ja) * | 2009-04-14 | 2010-10-21 | 関西ペイント株式会社 | ベースコート塗料組成物 |
WO2014196650A1 (ja) | 2013-06-07 | 2014-12-11 | 日産化学工業株式会社 | 生体物質の付着抑制能を有するイオンコンプレックス材料及びその製造方法 |
WO2016093293A1 (ja) | 2014-12-10 | 2016-06-16 | 日産化学工業株式会社 | 生体物質の付着抑制能を有するイオンコンプレックス材料及びその製造方法 |
WO2017131104A1 (ja) * | 2016-01-27 | 2017-08-03 | 日本ペイント・オートモーティブコーティングス株式会社 | プライマー塗料組成物および塗膜形成方法 |
WO2018194102A1 (ja) | 2017-04-21 | 2018-10-25 | 日清紡ケミカル株式会社 | ポリカルボジイミド化合物及びその製造方法、並びに樹脂組成物 |
Non-Patent Citations (1)
Title |
---|
See also references of EP4169991A4 |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2023080165A1 (ja) * | 2021-11-02 | 2023-05-11 | 日産化学株式会社 | 生体物質付着抑制材 |
Also Published As
Publication number | Publication date |
---|---|
TW202214726A (zh) | 2022-04-16 |
US20230235141A1 (en) | 2023-07-27 |
KR20230025427A (ko) | 2023-02-21 |
CN115698206A (zh) | 2023-02-03 |
CN115698206B (zh) | 2024-06-07 |
AU2021291562A1 (en) | 2023-02-16 |
EP4169991A1 (en) | 2023-04-26 |
JPWO2021256553A1 (ja) | 2021-12-23 |
EP4169991A4 (en) | 2024-01-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP7131585B2 (ja) | 生体物質の付着抑制能を有するイオンコンプレックス材料及びその製造方法 | |
EP3006529B1 (en) | Ion complex material having function of inhibiting adhesion of biological matter and production method for same | |
JP7235139B2 (ja) | 薄膜段差被覆性を有するコーティング膜、該膜を備える構造基体 | |
JP6969380B2 (ja) | 流路用コーティング剤 | |
JP6911852B2 (ja) | 凍結保存用容器 | |
WO2021256553A1 (ja) | リン酸基含有ポリマーを含むコーティング膜形成組成物 | |
EP3719113A1 (en) | Cell culture container capable of long-term culture, and method for manufacturing same | |
WO2021167037A1 (ja) | 生体物質付着抑制剤 | |
WO2020166605A1 (ja) | 生体物質への適合性を有するポリマーの製造方法 | |
WO2023080165A1 (ja) | 生体物質付着抑制材 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 21825606 Country of ref document: EP Kind code of ref document: A1 |
|
ENP | Entry into the national phase |
Ref document number: 2022531928 Country of ref document: JP Kind code of ref document: A |
|
ENP | Entry into the national phase |
Ref document number: 20237000293 Country of ref document: KR Kind code of ref document: A |
|
ENP | Entry into the national phase |
Ref document number: 2021825606 Country of ref document: EP Effective date: 20230119 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 2021291562 Country of ref document: AU Date of ref document: 20210618 Kind code of ref document: A |